Document:

Employment Agreement between Barry Karlin, CRC Health Group, Inc. and CRC Health

 Exhibit 10.5 
 EMPLOYMENT AGREEMENT 
 This EMPLOYMENT AGREEMENT (“Agreement”) is entered
into as of this 6th day of February, 2006, by and between CRC Health Group, Inc., a Delaware corporation (the “Company”), CRC Health Corporation, a Delaware corporation (the “OpCo”) and Barry Karlin
(“Executive”). 
 W I T N E S S E T H :

 WHEREAS, the Executive was previously employed under the terms of an Employment Agreement dated August 23, 2002 by CRC Holding
Corporation, one of OpCo’s Affiliates (“Prior Employment Agreement”). 
 WHEREAS, as a result of two mergers
that became effective on the date hereof, the Company (which was formerly known as CRCA Holdings, Inc) acquired and is the indirect parent company of the OpCo (which was formerly known as CRC Health Group, Inc.). 
 WHEREAS, the parties hereto agree that the Prior Employment Agreement is now cancelled. 
 WHEREAS, the Company and OpCo desire to employ Executive as the Chairman and Chief Executive Officer of the Company and OpCo and Executive desires to
accept such employment, in each case, on the terms and conditions set forth herein. 
 NOW, THEREFORE, in consideration of the premises and
the mutual covenants and promises contained herein and for other good and valuable consideration, the Company and Executive hereby agree as follows: 
 Section 1. Agreement to Employ; No Conflicts 
 Upon the terms and subject to the conditions of this Agreement, the Company
and OpCo hereby employ Executive, and Executive hereby accepts employment with the Company and OpCo. Executive represents that (a) he is entering into this Agreement voluntarily and that his employment hereunder and compliance with the
terms and conditions hereof will not conflict with or result in the breach by him of any agreement to which he is a party or by which he may be bound, (b) he has not violated, and in connection with his employment with the Company and
OpCo will not violate, any non-solicitation or other similar covenant or agreement by which he is or may be bound, and (c) in connection with his employment with the Company and OpCo he will not use any confidential or proprietary
information he may have obtained in connection with employment with any prior employer. 

 Section 2. Term; Position and Responsibilities 
 (a) Term of Employment. Unless Executive’s employment shall sooner terminate pursuant to Section 7, the Company and OpCo shall employ
Executive for a term commencing on the date hereof (the “Commencement Date”) and ending on the third anniversary thereof (the “Initial Term”). Effective upon the expiration of the Initial Term and of
each Additional Term (as defined below), Executive’s employment hereunder shall be deemed to be automatically extended, upon the same terms and conditions, for an additional period of one year (each, an “Additional
Term”), in each such case, commencing upon the expiration of the Initial Term or the then current Additional Term, as the case may be, unless, at least sixty (60) days prior to the expiration of the Initial Term or such Additional
Term, either party hereto shall have notified the other party hereto in writing that such extension shall not take effect. The period during which Executive is employed pursuant to this Agreement, including any extension thereof in accordance with
the preceding sentence, shall be referred to as the “Employment Period.” 
 (b) Position and Responsibilities.
During the Employment Period, Executive shall serve as Chairman and Chief Executive Officer of the Company and OpCo. The Executive shall have such duties and responsibilities as are customarily assigned to individuals serving in such position,
including without limitation duties and responsibilities with regard to the Company’s subsidiaries, and such other duties consistent with Executive’s title and position as the Board of Directors of the Company (the
“Board”) specifies from time to time. Executive shall devote all of his skill, knowledge and business time to the conscientious performance of the duties and responsibilities of such position, except for vacation time as set
forth in Section 6(c), absence for sickness or similar disability and time spent performing services for any charitable, religious or community organizations, so long as such services do not materially interfere with the performance of
Executive’s duties hereunder. Executive may act as a director for other companies, so long as his duties as an outside director do not materially interfere with Executive’s duties hereunder and subject to the prior consent of the Board
(such consent not to be unreasonably withheld). 
 Section 3. Base Salary 
 As compensation for the services to be performed by Executive during the Employment Period, OpCo shall pay Executive a base salary at an annualized rate
of Five Hundred and Seventy Five Thousand Dollars ($575,000), payable in installments on OpCo’s regular payroll dates (but no less frequently than monthly). The Board shall review Executive’s base salary annually during the Employment
Period and, in its sole discretion, may increase such base salary from time to time. The annual base salary payable to Executive under this Section 3, as the same may be increased from time to time, shall hereinafter be referred to as the
“Base Salary.” 
  

 -2- 

 Section 4. Incentive Compensation 
 (a) Cash Bonus. The Executive shall be eligible to receive an annual lump-sum performance incentive bonus (“Cash Bonus”) from OpCo based on his Base Salary in effect for the completed
year. The Cash Bonus shall be paid in the event the Company achieves the EBITDA or alternative operating metric determined in advance by the compensation committee of the Board (the “Compensation Committee”) under the annual
budget approved by the Board, as such budget may be amended by the Board during such year to reflect the Company’s acquisitions during the year (the “Bonus Target”). In the event that an alternative operating metric
other than EBITDA is used, such metric shall be determined by the Compensation Committee in consultation with the Executive. The amount of the Cash Bonus shall be determined as follows: 
 (i) If the Company achieves less than or equal to 90% of the Bonus Target during a year, then the Executive’s Cash Bonus with respect
to such year shall be zero. 
 (ii) If the Company achieves at least 90% but less than 100% of the Bonus Target during a year,
the Cash Bonus shall be a percentage of the Base Salary during such year equal to the product of (i) ten multiplied by (ii) the difference between (A) the percentage of the Bonus Target actually achieved for such year and
(B) 90%. 
 (iii) If the Company achieves at least 100% but less than 110% of the Bonus Target during a year, the Cash
Bonus shall be equal to a percentage of the Base Salary during such year equal to (i) 150% minus (ii) the product of (A) five multiplied by (B) the difference between (1) 110% and (2) the percentage of the Bonus Target
actually achieved for such year. 
 (iv) If the Company achieves greater than or equal to 110% of the Bonus Target during a
year, then the Executive’s Cash Bonus with respect to such year shall be 150% of the Base Salary during such year. 
 The Cash Bonus, if
any, shall be a pre-tax amount and shall be payable by OpCo on the earlier of (a) the date thirty (30) days after the close of the audit relating to the then-applicable year and (b) the end of the calendar year following the then
applicable calendar year. Nothing in this Agreement shall preclude or in any way limit the ability of the Compensation Committee to award Executive additional, discretionary bonus amounts. 
 Section 5. Employee Benefits 
 During the Employment
Period, Executive and, to the extent permitted under such plans, Executive’s family, shall be entitled to participate in the profit sharing, medical, 

  

 -3- 

 
disability and other welfare benefit plans at levels not less than those offered by OpCo to senior executives of OpCo on terms and conditions set forth in
such plans. OpCo shall pay 100% of all premiums relating to medical and dental insurance for Executive and his insured dependents. OpCo shall maintain a life insurance policy for Executive, the benefits of which shall be not less than three million
dollars ($3,000,000). Such policy shall be payable to Executive’s designated beneficiaries. 
 Section 6. Perquisites and Expenses 
 (a) General. During the Employment Period, Executive shall be entitled to participate in all perquisite programs maintained by OpCo for its senior
executives, on a basis that is commensurate with Executive’s position and duties with OpCo and the Company hereunder, in accordance with the terms thereof, as the same may be amended and in effect from time to time. 
 (b) Business Travel, Lodging, etc. OpCo shall reimburse Executive for reasonable travel, lodging, meal and other reasonable expenses incurred by
him in connection with his performance of services hereunder upon submission of evidence, satisfactory to OpCo, of the incurrence and purpose of each such expense and otherwise in accordance with OpCo’s expense substantiation policy applicable
to its senior executives as in effect from time to time (the “Expense Policy”). 
 (c) Vacation. During the
Employment Period, Executive shall accrue paid vacation at a rate of four weeks per year, provided, however, that the Executive shall be entitled to accrue a maximum of eight weeks of paid vacation. If at any time the maximum accrual
is reached, Executive shall not accrue further vacation benefits until he has taken sufficient vacation time to bring his accrued vacation balance below the maximum accrual permitted by section 6(c). 
 Section 7. Termination of Employment and Disability 
 (a) Termination Due to Death or Disability. In the event that Executive’s employment hereunder terminates due to his death or is terminated by the Company or OpCo due to Executive’s Disability (as defined below), no
termination benefits shall be payable to or in respect of Executive except as provided in Section 7(e)(ii). For purposes of this Agreement, “Disability” shall mean a physical or mental disability that prevents the
performance by Executive of his duties hereunder for a continuous period of 90 days or longer, or for 180 days or more in any 12-month period. 
 (b) Termination by the Company. The Company or OpCo may terminate Executive’s employment with the Company or OpCo with or without Cause. A termination for “Cause” shall mean a termination by the Company
or OpCo of Executive’s employment with the Company and OpCo following the occurrence of any 

  

 -4- 

 
of the following events: (i) the willful failure by Executive to substantially perform his duties hereunder (other than any such failure due to
Executive’s physical or mental illness), (ii) Executive’s engaging in willful and serious misconduct that has caused or is reasonably expected to result in injury to the Company or OpCo, (iii) Executive’s
conviction of, or entering a plea of guilty or nolo contendere to, a felony, or (iv) the breach by Executive of any of his obligations hereunder or under any other written agreement or covenant with the Company or any of its
Affiliates which breach results in or is reasonably expected to result in material harm to the Company or OpCo. With respect to (i) and (iv), the Company or OpCo must provide written notice to Executive of any failure or breach that the Company
or OpCo believes constitutes “Cause”, if in the Company’s and OpCo’s, as the case may be, sole determination such failure or breach is capable of cure. Executive will then be allowed fifteen (15) days to remedy the failure
or breach, in which case such failure or breach will not be grounds for termination under this Section. A termination for Cause shall include a determination by the Board within 100 days following the termination of the Employment Period that
circumstances existed during the Employment Period that would have justified a termination by the Company or OpCo for Cause. 
 (c)
Termination by Executive. Executive may terminate his employment with the Company or OpCo with or without Good Reason. A termination of employment by Executive for “Good Reason” shall mean a termination by Executive of
his employment with the Company and OpCo, by written notice to the Company specifying in reasonable detail the circumstances claimed to provide the basis for such termination, within 30 days following the occurrence, without Executive’s written
consent, of any of the following events and the failure of the Company or OpCo to correct the circumstances set forth in Executive’s written notice within 30 days of receipt of such notice: (i) the assignment to Executive of duties
that are significantly different from, and that result in a substantial diminution of, the duties that he is to assume on the Commencement Date, (ii) any change in Executive’s title that is different from that which he is to assume
as of the Commencement Date and which change is not consented to by Executive; (iii) a reduction in the rate of Executive’s Base Salary or formula with respect to Executive’s incentive compensation, unless such reduction is
implemented in connection with an across the board reduction of the base salaries and incentive compensation of all senior executives of OpCo and is not greater than 10% of Executive’s Base Salary or incentive compensation formula, as the case
may be, (iv) a material breach of this Agreement by the Company or OpCo, (v) if, for any reason other than a reason constituting Cause, the Company or OpCo provides notice to Executive that it will not renew Executive’s
employment for an Additional Term pursuant to the terms of Section 2 of this Agreement; (vi) a change in the principal work location of the Executive to a location greater than 50 miles from Executive’s primary location with
the Company, without the consent of Executive; or (vii) any failure by the Company or OpCo to have any successor or assign assume in writing all of the Company’s and OpCo’s obligations and liabilities under this Agreement in
accordance with Section 15(a). Executive agrees that a 

  

 -5- 

 
corporate reorganization by the Company, OpCo and/or their Affiliates pursuant to which the Company or OpCo ceases to exist or Executive’s title is
changed shall not constitute Good Reason hereunder so long as there is no substantial diminution or significant change in the nature of Executive’s duties described herein. 
 (d) Notice of Termination. Any termination of Executive’s employment by the Company or OpCo pursuant to Section 7(a) or 7(b), or by
Executive pursuant to Section 7(c), shall be communicated by a written Notice of Termination addressed to the other parties to this Agreement. A “Notice of Termination” shall mean a notice stating that Executive’s
employment with Company or OpCo has been or will be terminated and the specific provisions of this Section 7 under which such termination is being effected. In the event Executive terminates employment without Good Reason, the applicable Notice
of Termination shall set forth a date of termination which is at least 60 days following the communication of such Notice of Termination to the other parties to this Agreement pursuant to this Section 7(d). 
 (e) Payments Upon Certain Terminations. 
 (i) In the event of a termination of Executive’s employment by the Company or OpCo without Cause or a termination by Executive of his employment for Good Reason in either such case during the Employment Period,
OpCo shall pay to Executive (or, following his death, to Executive’s beneficiaries) (t) the Base Salary earned but not paid through the date of termination, (u) any vacation time accrued in accordance with this Agreement but not used
through the date of termination, (v) any bonus compensation earned but unpaid on the date of termination and (w) any business expenses incurred by Executive but un-reimbursed on the date of termination, provided that such expenses and
required substantiation and documentation are submitted within thirty (30) days of termination and that such expenses are reimbursable under OpCo company policy (“Final Compensation”) plus, as liquidated damages in
respect of claims based on provisions of this Agreement and provided that within 60 days following the Date of Termination Executive executes, delivers and does not revoke a general release substantially in the form attached to this Agreement as
Exhibit A (subject to such adjustments as are delivered by the Company to Executive within ten (10) days after the Date of Termination and as may be necessary in the Company’s determination to ensure a comprehensive release of
claims by Executive under the law in effect at the date of the execution of the release), a lump sum equal to his Base Salary for a period of Thirty Six (36) months (“Liquidated Damages”). In addition, in the event
Executive’s employment is terminated by the Company or OpCo without Cause or by Executive for Good Reason in either such case during the Employment Period and provided that Executive executes, delivers and does not revoke a general release of
all claims in form and substance satisfactory to the Company, for a period of 

  

 -6- 

 
Eighteen (18) months, OpCo shall pay as such premiums come due (x) all COBRA premiums for Executive and his insured dependants; (y) all
premiums for Executive relating to OpCo’s group disability plan; and (z) all premiums relating to the life insurance policy described in Section 5. 
 (ii) If Executive’s employment shall terminate due to his death or Disability or if the Company or OpCo shall terminate
Executive’s employment for Cause or Executive shall terminate his employment without Good Reason, in each case, during the Employment Period, OpCo shall pay Executive (or, in the event of his death, his beneficiaries) Final Compensation.

 (iii) In the event that Executive’s employment with the Company or OpCo is terminated for any reason, Executive shall
be entitled to receive all amounts payable and benefits accrued under any otherwise applicable plan, policy, program or practice of the Company or OpCo in which Executive was a participant during his employment with Company and OpCo in accordance
with the terms thereof (other than any plan that would provide severance, as severance is explicitly covered herein); provided that Executive shall not continue to accrue any additional benefits, including vacation benefits, after the Date of
Termination. 
 (f) Date of Termination. As used in this Agreement, the term “Date of Termination” shall mean
(i) if Executive’s employment is terminated by his death, the date of his death, and (ii) if Executive’s employment is terminated for any other reason, the latest of the date on which Notice of Termination is given
as contemplated by Section 7(d), the date of termination specified in such notice, and the date any applicable correction period ends; provided that if Executive’s employment with the Company or OpCo is terminated by Executive without Good
Reason, the date that is 60 days after the date on which Notice of Termination is given as contemplated by Section 7(d) or, if no such notice is given, 60 days after the date of termination of employment (“Notice
Period”). 
 (g) Resignation upon Termination. Effective as of any Date of Termination under this Section 7 or
otherwise as of the date of Executive’s termination of employment with Company or OpCo, Executive shall be deemed to have resigned from all positions then held by him with the Company, OpCo and their Affiliates. Upon request of the Company or
OpCo, Executive will promptly execute and deliver written confirmation of such resignation. 
 (h) Cessation of Professional Activity.
Upon delivery of a Notice of Termination by any party, the Company or OpCo may relieve Executive of his responsibilities described in Section 2(b) and require Executive to immediately cease all professional activity on behalf of the Company and
OpCo. Whether the Company or OpCo relieves Executive of his duties pursuant to this Section or not, OpCo shall continue to pay Executive’s wages and benefits through the Date of Termination. 
  

 -7- 

 (i) Disability 
 (i) The Board may designate another employee to act in Executive’s place during any period of Executive’s disability.
Notwithstanding any such designation, Executive shall continue to receive the Base Salary in accordance with Section 3, any Cash Bonus that has been earned in accordance with Section 4 but not paid, and benefits in accordance with
Section 5, to the extent permitted by the then-current terms of the applicable benefit plans, until Executive becomes eligible for disability income benefits under the Company’s or OpCo’s disability income plan or until the
termination of his employment, whichever shall first occur. 
 (ii) While receiving disability income payments under the
Company’s or OpCo’s disability income plan, Executive shall not be entitled to receive any Base Salary under Section 3 hereof, but shall continue to participate in Company and OpCo benefit plans in accordance with Section 5 and
the terms of such plans, until the termination of his employment. 
 (iii) If any question shall arise as to whether during
any period Executive is disabled through any illness, injury, accident or condition of either a physical or psychological nature so as to be unable to perform substantially all of his duties and responsibilities hereunder, Executive may, and at the
request of the Company or OpCo shall, submit to a medical examination by a physician selected by the Company or OpCo to whom Executive or his duly appointed guardian, if any, has no reasonable objection to determine whether Executive is so disabled
and such determination shall for the purposes of this Agreement be conclusive of the issue. If such question shall arise and Executive shall fail to submit to such medical examination, the Company’s determination of the issue shall be binding
on Executive. 
 (j) Timing of Payments. Final Compensation, except for any bonus compensation earned but unpaid on the Date of
Termination, shall be paid on the date of the Company’s next regularly occurring payroll date. Any bonus compensation earned but unpaid on the Date of Termination, shall be paid on the earlier of (a) the date thirty (30) days after
the close of the audit relating to the calendar year to which such bonus compensation relates and (b) the end of the calendar year containing the Date of Termination. Liquidated Damages, if any, shall be paid within ten (10) days of the
expiration of the revocation period of the general release delivered to the Company by the Executive. In the event that at the time Executive’s employment with the Company or OpCo terminates the Company or OpCo is publicly traded (as defined in
Section 409A of 

  

 -8- 

 
the Code), any amounts payable under this Section 7 that would otherwise be considered deferred compensation subject to the additional twenty percent
(20%) tax imposed by Section 409A of the Code if paid within six (6) months following the date of termination of Company or OpCo employment shall be paid at the later of the time otherwise provided in Section 7 or the time that
will prevent such amounts from being subject to such tax imposed by Section 409A of the Code. 
 Section 8. Effect of Termination. 
 The provisions of this Section 8 shall apply to termination due to the expiration of the term hereof, pursuant to Section 7 or otherwise.

 (a) (i) To the extent that any of the payments and benefits provided for in this Agreement or otherwise payable to the Employee
(collectively, the “Payments”) would (but for shareholder approval within the meaning of Section 280G(b)(5)(B) of the Code) result in a “parachute payment” within the meaning of Code section 280G, the Company
and OpCo will use commercially reasonable efforts to obtain shareholder approval (within the meaning of section 280G(b)(5)(B) of the Code) of such Payments, provided that if such shareholder approval is not obtained then, the
amount of such Payments shall be either: (a) the full amount of the Payments, or (b) a reduced amount which would result in no portion of the Payments being subject to the excise tax imposed pursuant to Section 4999 of the Code (the
“Excise Tax”), whichever of the foregoing amounts, taking into account the applicable federal, state and local income taxes and the Excise Tax, results in the receipt by the Employee, on an after-tax basis, of the greatest
amount of benefit. 
 (a) (ii) Any determination required under Section 8(a) (i) shall be made in writing by independent
public accountants appointed by the Company (the “Accountants”), whose determination shall be conclusive and binding upon the Employee, the Company and OpCo for all purposes. The Employee shall bear all costs the Accountants
may reasonably incur in connection with such determination, and the Company, OpCo and the Employee shall furnish to the Accountants such information and documents as the Accountants may reasonably request in order to make a determination under this
Subsection. 
 (b) Payment by OpCo of the amounts owed under Section 7(e) shall constitute the entire obligation of the Company and OpCo
to Executive. Executive shall promptly give the Company and OpCo notice of all facts necessary for the Company and OpCo to determine the amount and duration of their obligations in connection with any termination pursuant to Section 7(e)(i)
hereof. 
 (c) Except for medical and dental plan coverage, disability coverage and life insurance continued pursuant to Section 7(e)(i)
hereof and any options or other awards 

  

 -9- 

 
under any equity incentive plan of the Company or OpCo (which shall terminate in accordance with their terms), benefits shall terminate pursuant to the terms
of the applicable benefit plans based on the date of termination of Executive’s employment without regard to any continuation of Base Salary or other payment to Executive following such date of termination. 
 (d) Provisions of this Agreement shall survive any termination if so provided herein or if necessary or desirable to accomplish the purposes of other
surviving provisions, including without limitation the obligations of the Executive under Section 9 hereof. The Executive recognizes that, except as expressly provided in Section 7(e)(i), no compensation shall be earned after termination
of employment. 
 Section 9. Restrictive Covenants 
 (a) Unauthorized Disclosure. From the date hereof, and during any period of employment with the Company, OpCo or their Affiliates and the ten-year period following any termination thereof, without the prior
written consent of the Board or its authorized representative, except to the extent required by law or an order of a court having jurisdiction or under subpoena from an appropriate government agency, in which event, Executive shall use
Executive’s best efforts to consult with the Board prior to responding to any such order or subpoena, and except as required in the performance of his duties hereunder, Executive shall not disclose any confidential or proprietary trade secrets,
customer lists, referral sources, drawings, designs, information regarding product development, marketing plans, sales plans, manufacturing plans, management organization information (including but not limited to data and other information relating
to members of the Board, the Company, OpCo or any of their Affiliates or to the management of the Company, OpCo or any of their Affiliates), operating policies or manuals, business plans, financial records, packaging design or other financial,
commercial, business or technical information (a) relating to the Company, OpCo or any of their Affiliates or (b) that the Company, OpCo or any of their Affiliates may receive belonging to suppliers, customers, referral
sources or others who do business with the Company, OpCo or any of their Affiliates (collectively, “Confidential Information”) to any third Person (as defined below) unless such Confidential Information has been previously
disclosed to the public or is in the public domain (in each case, other than by reason of Executive’s breach of this Section 9(a)). 
 (b) Non-Disparagement. From the date hereof, and during any period of employment with the Company, OpCo or their Affiliates and at any time thereafter, Executive will not directly or indirectly, engage in any conduct or make any
statement, whether in commercial or noncommercial speech, disparaging or criticizing in any way the Company, OpCo, Bain Capital, LLC or any of their respective Affiliates, or any products or services offered by any of these, nor shall he engage in
any other conduct or make any other statement that could be reasonably expected to impair the goodwill of the 

  

 -10- 

 
Company, OpCo, Bain Capital, LLC or any of their respective Affiliates, the reputation of Company or OpCo products or the marketing of Company or OpCo
products, in each case except to the extent required by law, and then only after consultation with the Company and OpCo to the extent possible. 
 (c) Non-Competition. During the period commencing on the date hereof and ending eighteen (18) months after the termination of Executive’s employment with the Company and OpCo (the “Restriction
Period”), Executive shall not, except with the prior written consent of the Board, directly or indirectly, own any interest in, operate, join, control or participate as a partner, director, principal, officer, or agent of, enter into
the employment of, act as a consultant to, or perform any services for any entity which has material operations which competes with (i) any chemical or alcohol dependency treatment business or (ii) any business pertaining to behavioral
health in which the Company, OpCo or their Affiliates was, or had documented plans to become, materially involved during the Executive’s tenure with the Company or OpCo, in each case in any jurisdiction in which the Company, OpCo or any of
their Affiliates is engaged, or in which any of the foregoing has documented plans to become engaged of which Executive has knowledge at the time of Executive’s termination of employment. Notwithstanding anything herein to the contrary, the
foregoing shall not prevent Executive from acquiring as an investment securities representing not more than two percent (2%) of the outstanding voting securities of any publicly held corporation. 
 (d) Non-Solicitation of Employees. Acknowledging the strong interest of the Company, OpCo and their Affiliates in an undisrupted workplace, during
the Restriction Period, Executive shall not, and shall not assist any Person to, (a) hire or solicit for hiring any employee or former employee of the Company, OpCo or their Affiliates or seek to persuade any employee of the Company, OpCo or
their Affiliates to discontinue employment or (b) solicit or encourage any independent contractor providing services to the Company, OpCo or their Affiliates to terminate or diminish its relationship with the Company, OpCo or their Affiliates.

 (e) Non-Solicitation of Customers, Referral Sources or Suppliers. Executive acknowledges that his access to Confidential
Information and to the Company’s, OpCo’s and their Affiliates’ referral sources and customers and his development of goodwill on behalf of the Company, OpCo and their Affiliates with their referral sources and customers during his
employment would give him an unfair competitive advantage were he to leave employment and begin competing with the Company, OpCo or their Affiliates for their existing referral sources and customers and that he is therefore being granted access to
Confidential Information and to the referral sources and customers of the Company, OpCo and their Affiliates in reliance on his agreement hereunder. Executive therefore agrees that, during the Restriction Period, he will not solicit or encourage any
referral source or customer of the Company, OpCo or their Affiliates to terminate or diminish its relationship with the Company, OpCo or their Affiliates and he will not seek 

  

 -11- 

 
to persuade any such referral source or customer to conduct with any Person any business or activity which such referral source or customer conducts or could
conduct with the Company, OpCo or their Affiliates; provided, however, that these restrictions shall apply only with respect to those Persons who are referral sources or customers of the Company, OpCo or their Affiliates at any time during his
employment or whose business has been solicited on behalf of the Company or OpCo by any of their employees or agents, other than by form letter, blanket mailing or published advertisement, within one year prior to the date his employment ends.

 (f) Return of Documents. In the event of the termination of Executive’s employment for any reason, Executive shall deliver to
the Company all of (a) the property of each of the Company, OpCo and their Affiliates and (b) the documents and data of any nature and in whatever medium of each of the Company, OpCo and their Affiliates, and Executive shall
not take with Executive any such property, documents or data or any reproduction thereof, or any documents containing or pertaining to any Confidential Information other than those documents to which he is legally entitled, including, as the case
may be, the Executive’s personnel file. 
 (g) Works for Hire. Executive agrees to maintain accurate and complete contemporaneous
records of, and shall immediately and fully disclose and deliver to the Company, all Intellectual Property, as defined below. Executive hereby assigns and agrees to assign to the Company (or as otherwise directed by the Company) his full right,
title and interest in and to all Intellectual Property. Executive agrees to execute any and all applications for domestic and foreign patents, copyrights and other proprietary rights and do such other acts (including, among others, the execution and
delivery of instruments of further assurance or confirmation) requested by the Company to assign the Intellectual Property to the Company or OpCo and to permit the Company and OpCo to enforce any patents, copyrights and other proprietary rights in
the Intellectual Property. Executive will not charge the Company or OpCo for time spent in complying with these obligations. All copyrightable works that Executive creates, including without limitation computer programs and documentation, shall be
considered “work made for hire” and shall, upon creation, be owned exclusively by the Company or OpCo. 
  

 -12- 

 Section 10. Notification Requirement 
 Until the conclusion of the Restriction Period, Executive shall give notice to the Company of each new business activity he plans to undertake, at least thirty (30) days prior to beginning any such activity. Such
notice shall state the name and address of the Person for whom such activity is undertaken and the nature of Executive’s business relationship(s) and position(s) with such Person. Executive shall provide the Company with such other pertinent
information concerning such business activity as the Company may reasonably request in order to determine Executive’s continued compliance with his obligations under Sections 9 hereof. 
 Section 11. Injunctive Relief with Respect to Covenants; Certain Acknowledgments; Forfeiture 
 (a) Executive acknowledges and agrees that Executive will have a prominent role in the management of the business, and the development of the goodwill, of
the Company, OpCo and their Affiliates and will establish and develop relations and contacts with the principal referral sources, customers and suppliers of the Company, OpCo and their Affiliates in the United States of America and the rest of the
world, all of which constitute valuable goodwill of, and could be used by Executive to compete unfairly with, the Company, OpCo and their Affiliates and that (i) in the course of his employment with the Company, Executive will obtain
confidential and proprietary information and trade secrets concerning the business and operations of the Company, OpCo and their Affiliates in the United States of America and the rest of the world that could be used to compete unfairly with the
Company, OpCo and their Affiliates; (ii) the covenants and restrictions contained in Section 9 are intended to protect the legitimate interests of the Company, OpCo and their Affiliates in their respective goodwill, trade secrets
and other confidential and proprietary information; and (iii) Executive desires to be bound by such covenants and restrictions. 
 (b) Executive acknowledges and agrees that the covenants, obligations and agreements of Executive contained in Section 9 relate to special, unique and extraordinary matters and that a violation of any of the terms of such covenants,
obligations or agreements will cause the Company and OpCo irreparable injury for which adequate remedies are not available at law. Therefore, Executive agrees that the Company and OpCo shall be entitled to an injunction, restraining order or such
other equitable relief (without the requirement to post bond) as a court of competent jurisdiction may deem necessary or appropriate to restrain Executive from committing any violation of such covenants, obligations or agreements. These injunctive
remedies are cumulative and in addition to any other rights and remedies the Company and OpCo may have. 
  

 -13- 

 (c) Executive agrees that in the event Executive breaches any provision of Section 9 hereof in any
material respect following the Date of Termination, Executive shall (i) not be entitled to receive, if not already paid, the benefits described in Section 7(e)(i) hereof, and (ii) return to OpCo any and all payments
previously made by OpCo (or any of its Affiliates) pursuant to Section 7(e)(i) within 15 days after written demand for such repayment is made to Executive by OpCo. 
 Section 12. Definitions 
 For purposes of this Agreement, the following definitions apply: 

“Affiliates” means all persons and entities directly or indirectly controlling, controlled by or under common control with the Company or
OpCo, as the case may be, where control may be by management authority, equity interest or otherwise. 
 “Code” means the Internal
Revenue Code of 1986, as amended. Any reference to a Code section shall include a reference to any regulations (final, temporary or proposed, as applicable, as determined by the Company) promulgated pursuant to that section. 
 “Confidential Information” means any and all information of the Company, OpCo or their Affiliates that is not generally available to the
public, including but not limited to (i) the products and services, technical data, methods and processes of the Company or OpCo, (ii) their marketing activities and strategic plans, (iii) their costs and sources of supply,
(iv) the identity and special needs of their referral sources and customers and (v) the people and organizations with whom the Company or OpCo have business relationships and the substance of those relationships. Confidential Information
also includes any information that the Company, OpCo or their Affiliates may receive or have received, from referral sources and customers or others, with any understanding, express or implied, that the information would not be disclosed.

 “Intellectual Property” means any invention, formula, process, discovery, development, design, innovation or improvement
(whether or not patentable or registrable under copyright statutes) made, conceived, or first actually reduced to practice by Executive solely or jointly with others, during his employment by the Company, OpCo or their Affiliates; provided, however,
that, as used in this Agreement, the term “Intellectual Property” shall not apply to any invention that Executive develops on his own time, without using the equipment, supplies, facilities or trade secret information of the Company, OpCo
or their Affiliates, unless such invention relates at the time of conception or reduction to practice of the invention (a) to the business of the Company, OpCo or their Affiliates, (b) to the actual or demonstrably anticipated research or
development of the Company, OpCo or their Affiliates or (c) results from any work performed by Executive for the Company, OpCo or their Affiliates. 
  

 -14- 

 “Person” means an individual, a corporation, a limited liability company, an association, a
partnership, an estate, a trust and any other entity or organization, other than the Company, OpCo or their Affiliates. 
 Section 13. Entire Agreement

 This Agreement, together with any options issued under the Company’s 2006 Executive Incentive Plan or in connection with the
mergers referred to in the recitals of this Agreement, constitute the entire agreement among the parties hereto with respect to the subject matter hereof, and supersede all undertakings and agreements, whether oral or in writing, previously entered
into by the parties with respect thereto. Notwithstanding the foregoing, except as expressly provided herein, Executive’s rights and obligations with respect to securities of the Company remain in full force and effect and shall survive the
termination or expiration of this Agreement and/or the termination of Executive’s employment, if so provided in those agreements. All prior correspondence and proposals (including but not limited to summaries of proposed terms) and all prior
promises, representations, understandings, arrangements and agreements relating to such subject matter (including but not limited to those made to or with Executive by any other Person) are merged herein and superseded hereby. 
 Section 14. Indemnification 
 The Company and OpCo
hereby agree that they shall indemnify and hold harmless Executive to the fullest extent permitted by law from and against any and all liabilities, costs, claims and expenses, including all costs and expenses incurred in defense of litigation
(including attorneys’ fees), arising out of the employment of Executive hereunder, within the scope of his employment, other than any claim by the Company or OpCo for Executive’s breach of this Agreement. Costs and expenses incurred by
Executive in defense of such litigation (including attorneys’ fees) shall be paid by OpCo in advance of the final disposition of such litigation upon receipt by OpCo of (a) a written request for payment, (b) appropriate
documentation evidencing the incurrence, amount and nature of the costs and expenses for which payment is being sought, and (c) an undertaking adequate under applicable law made by or on behalf of Executive to repay the amounts so paid
if it shall ultimately be determined that Executive is not entitled to be indemnified by the Company or OpCo under this Agreement. The Company, OpCo and Executive will consult in good faith with respect to the conduct of any such litigation, and
Executive’s counsel shall be selected with the consent of the Company, such consent not to be unreasonably withheld. 
 Section 15. Miscellaneous

 (a) Binding Effect; Assignment. This Agreement shall be binding on and inure to the benefit of the Company and OpCo, and their
respective successors and 

  

 -15- 

 
permitted assigns, provided such successors and assigns assume all of the Company’s and OpCo’s obligations and liabilities under this Agreement in
writing. This Agreement shall also be binding on and inure to the benefit of Executive and his heirs, executors, administrators and legal representatives. This Agreement shall not be assignable by any party hereto without the prior written consent
of the other parties hereto, except as provided pursuant to this Section 15(a). The Company or OpCo may effect such an assignment without prior written approval of Executive upon the transfer of all or substantially all of its business and/or
assets (by whatever means). 
 (b) Governing Law, etc. 
 (i) This agreement shall be governed in all respects, including as to validity, interpretation and effect, by the internal laws of the
State of California without giving effect to the conflict of laws rules thereof to the extent that the application of the law of another jurisdiction would be required thereby. 
 (ii) EACH PARTY ACKNOWLEDGES AND AGREES THAT ANY CONTROVERSY WHICH MAY ARISE UNDER THIS AGREEMENT IS LIKELY TO INVOLVE COMPLICATED AND
DIFFICULT ISSUES, AND THEREFORE EACH PARTY HEREBY IRREVOCABLY AND UNCONDITIONALLY WAIVES ANY RIGHT SUCH PARTY MAY HAVE TO A TRIAL BY JURY IN RESPECT OR ANY LITIGATION DIRECTLY OR INDIRECTLY ARISING OUT OF OR RELATING TO THIS AGREEMENT, OR THE
BREACH, TERMINATION OR VALIDITY OF THIS AGREEMENT, OR THE TRANSACTIONS CONTEMPLATED BY THIS AGREEMENT. Each party certifies and acknowledges that (i) no representative, agent or attorney of any other party has represented, expressly or
otherwise, that such other party would not, in the event of litigation, seek to enforce the foregoing waiver, (ii) each such party understands and has considered the implications of this waiver, (iii) each such party makes
this waiver voluntarily, and (iv) each such party has been induced to enter into this agreement by, among other things, the mutual waivers and certifications in this Section 15(b). 
 (c) Fees and Costs Relating to this Agreement. 
 (i) OpCo agrees to reimburse Executive’s reasonable attorneys’ fees incurred in negotiating and documenting this Agreement to a maximum of Six Thousand Dollars ($6,000), subject to receipt of reasonable
substantiation and documentation of such attorneys’ fees by OpCo within sixty (60) days of the date of this Agreement. 
 (ii) An award of reasonable attorneys’ fees and costs shall be made to the prevailing party in any litigation concerning this agreement. 
  

 -16- 

 (d) Determination of Fair Market Value. Reference is hereby made to the Stockholders Agreement
among the Company, CRC Intermediate Holdings, Inc., OpCo and the Investors, Other Investors and Managers named therein, dated as of the date hereof and as amended from time to time (the “Stockholders Agreement”). In the event
that the Company exercises its rights to call any of your Shares (as defined in the Stockholders Agreement) pursuant to Section 5 of the Stockholders Agreement and you disagree with the Board’s good faith determination of the Fair Market
Value (as defined in the Stockholders Agreement) of any such Shares, then within 10 business days of your receipt of the Board’s determination you may submit to the Board your statement of the Fair Market Value of such Shares and the Company
shall select a recognized investment banking or accounting firm, reasonably acceptable to you, to review the two proposals. Such firm shall be instructed to, within 20 business days of appointment, appraise and determine the Fair Market Value of the
Shares, which determination shall be final and binding upon you and the Company. The fees and expenses of such investment banking or accounting firm shall be paid by the party whose proposal for the Fair Market Value of the Shares is farthest (on an
absolute basis) from the Fair Market Value of the Shares as finally determined by the investment banking or accounting firm. Closing may be delayed if necessary to permit final determination of Fair Market Value hereunder. 
 (e) Taxes. The Company and OpCo shall have the power to withhold, or require Executive to remit to OpCo promptly upon notification of the amount
due, an amount sufficient to satisfy the statutory minimum amount of all Federal, state, local and foreign withholding tax requirements with respect to any payment of cash, or issuance or delivery of any other property hereunder to Executive, and
OpCo may defer any such payment of cash or issuance or delivery of such other property until such requirements are satisfied. 
 (f)
Amendments. No provision of this Agreement may be modified, waived or discharged unless such modification, waiver or discharge is approved by the Board or a Person authorized thereby and is agreed to in writing by Executive, the Company and
OpCo. No waiver by any party hereto at any time of any breach by any other party hereto of, or compliance with, any condition or provision of this Agreement to be performed by such other party shall be deemed a waiver of similar or dissimilar
provisions or conditions at the same or at any prior or subsequent time. No waiver of any provision of this Agreement shall be implied from any course of dealing between or among the parties hereto or from any failure by any party hereto to assert
its rights hereunder on any occasion or series of occasions. 
 (g) Severability. In the event that any one or more of the provisions
of this Agreement shall be or become invalid, illegal or unenforceable in any respect, the validity, legality and enforceability of the remaining provisions contained herein shall not be affected thereby. 
  

 -17- 

 (h) Blue Pencil. The Executive, the Company and OpCo agree that the covenants contained in
Section 9 hereof are reasonable covenants under the circumstances, and further agree that if, in the opinion of any court of competent jurisdiction such covenants are not reasonable in any respect, such court shall have the right, power and
authority to (and it is the intent of the Executive, the Company and OpCo that such court shall) excise or modify such provision or provisions of these covenants as to the court shall appear not reasonable and to enforce the remainder of these
covenants as so amended. 
 (i) Notices. Any notice or other communication required or permitted to be delivered under this Agreement
shall be (i) in writing, (ii) delivered personally, by courier service or by certified or registered mail, first-class postage prepaid and return receipt requested, (iii) deemed to have been received on the date
of delivery or, if so mailed, on the third business day after the mailing thereof, and (iv) addressed as follows (or to such other address as the party entitled to notice shall hereafter designate in accordance with the terms hereof):

 (A) If to the Company or OpCo, to it at: 
 CRC Health Group, Inc. 
 CRC Health Corporation 
 20400 Stevens Creek Boulevard, Suite 600 
 Cupertino, CA 95014 
 Tel: (408) 367-0036 
 Fax: (408) 367-0037  
 Attention: General Counsel 
 (B) if to Executive, to him at his residential address as currently on file with OpCo. 
  

 -18- 

 (C) Copies of any notices or other communications given under this Agreement shall also be given to:

 Bain Capital Partners, LLC 
 111 Huntington Avenue 
 Boston, Massachusetts 02199 
 Tel: (617) 516-2000 
 Fax: (617) 516-2010 
 Attention: John P. Connaughton 
                    Steve Barnes 
                    Chris Gordon 
 and to:

 Ropes & Gray LLP 
 One
International Place 
 Boston, Massachusetts 02110 
 Tel: (617) 951-7000 
 Fax: (617) 951-7050 
 Attention: Alfred O. Rose, Esq. 
 (j)
Counterparts. This Agreement may be executed in counterparts, each of which shall be deemed an original and all of which together shall constitute one and the same instrument. 
 (k) Headings. The section and other headings contained in this Agreement are for the convenience of the parties only and are not intended to be a
part hereof or to affect the meaning or interpretation hereof. 
 [The remainder of this page has been intentionally left blank] 

 

 -19- 

 IN WITNESS WHEREOF, the Company and OpCo have duly executed this Agreement by their authorized
representative, and Executive has hereunto set his hand, in each case effective as of the date first above written. 
  

			
	 CRC HEALTH GROUP INC.

		
	By:	 	/s/ Pamela B. Burke
		 	 Name: Pamela Burke

		 	 Title:   Vice President and General Counsel

  

			
	CRC HEALTH CORPORATION
		
	By:	 	/s/ Pamela B. Burke
		 	 Name: Pamela Burke

		 	 Title:   Vice President and General Counsel

  

	
	EXECUTIVE
	
	/s/ Barry Karlin
	 Barry Karlin

  

 -20- 

 EXHIBIT A 
 RELEASE OF CLAIMS 
 FOR AND IN CONSIDERATION OF the special payments to be made to me in connection with my
separation of employment, as set forth in the Employment Agreement between me, CRC Health Group Inc., (the “Company”) and CRC Health Corporation (“OpCo”) and dated as of February 6, 2006 (the “Employment
Agreement”), I, on my own behalf and on behalf of my heirs, beneficiaries and representatives and all others connected with me, hereby release and forever discharge the Company, OpCo, their Affiliates (as that term is defined in the Employment
Agreement), and all of their respective officers, directors, trustees, employees, agents, representatives, successors and assigns and all others connected with them, both individually and in their official capacities (but, with respect to such
individuals, only to the extent relating to my employment with the Company or OpCp or its termination), from any and all liabilities, claims, demands, actions and causes of action of any type which I have had in the past, now have, or might now
have, through the date of my execution of this Release of Claims, including but not limited to any and all liabilities, claims, demands, actions and causes of action in any way resulting from, arising out of or connected with my employment or its
termination or pursuant to any federal, state or local employment law, regulation or other requirement (including without limitation Title VII of the Civil Rights Act of 1964, the Age Discrimination in Employment Act, the Americans with Disabilities
Act, and the fair employment practices statutes of the state or states in which have provided services to the Company, each as may be amended from time to time). 
 Excluded from the scope of this Release of Claims is any right of indemnification pursuant to the Employment Agreement or any other contract, any by-laws of the Company or Opco or any applicable statute, that I have
or hereafter acquire if any claim is asserted or proceedings are brought against me related or allegedly related to my having been an officer or employee of the Company or OpCo or to any of my activities as an officer or employee of the Company or
OpCo. 
 In signing this Release of Claims, I acknowledge my understanding that I may consider the terms of this Release of Claims for at
least forty-five (45) days from the date of my sending or receipt of notice of termination of my employment, as applicable, before signing; that I am encouraged by the Company and OpCo to seek the advice of an attorney prior to signing this
Release of Claims; and that I am signing this Release of Claims voluntarily and with a full understanding of its terms. I understand that I may revoke this Release of Claims at any time within seven (7) days of the date of my signing by written
notice to the Company and OpCo and that this Release of Claims will take effect only upon the expiration of such seven-day revocation period and only if I have not timely revoked it. 
  

 -21- 

 Intending to be legally bound, I have signed this Release of Claims under seal on the date written below.

 Signature:
                                        
                                        

 Date Signed:
                                        
                                     
  

 -22-Stockholder Agreement among CRC Health Group, Inc.

 Exhibit 10.6 
 Execution Version 
 STOCKHOLDERS AGREEMENT 
 AMONG 
 CRC HEALTH GROUP, INC. (F/K/A CRCA
HOLDINGS, INC.), 
 CRC INTERMEDIATE HOLDINGS, INC., 
 CRC HEALTH CORPORATION (F/K/A CRC HEALTH GROUP, INC.) 
 AND 
 THE INVESTORS, OTHER INVESTORS 
 AND MANAGERS
NAMED HEREIN 
 DATED AS OF FEBRUARY 6, 2006 

 TABLE OF CONTENTS 
  

							
	 	  	 	  	 	  	Page
	1.	  	EFFECTIVENESS; DEFINITIONS.	  	1
		  	1.1.	  	Closing	  	1
		  	1.2.	  	Definitions	  	2
	2.	  	VOTING AGREEMENT.	  	2
		  	2.1.	  	Election of Directors	  	2
		  	2.2.	  	Significant Transactions	  	2
		  	2.3.	  	Consent to Amendment	  	2
		  	2.4.	  	Grant of Proxy	  	2
		  	2.5.	  	The Company	  	2
		  	2.6.	  	Period	  	2
	3.	  	TRANSFER RESTRICTIONS	  	2
		  	3.1.	  	Permitted Transferees.	  	3
		  	3.2.	  	Tag Alongs, Drag Alongs, Etc	  	4
		  	3.3.	  	Transfers to the Public	  	4
		  	3.4.	  	Transfers Pursuant to Section 5	  	5
		  	3.5.	  	Impermissible Transfer	  	5
		  	3.6.	  	Period	  	5
	4.	  	INVESTOR TRANSFER RIGHTS; “TAG ALONG” AND “DRAG ALONG” RIGHTS.	  	5
		  	4.1.	  	Tag Along	  	5
		  	4.2.	  	Drag Along	  	7
		  	4.3.	  	Miscellaneous	  	8
		  	4.4.	  	Period	  	10
	5.	  	OPTIONS TO PURCHASE MANAGEMENT SHARES.	  	10
		  	5.1.	  	Call Options	  	10
		  	5.2.	  	Closing.	  	12
		  	5.3.	  	Investor Call Option	  	14
		  	5.4.	  	Acknowledgment	  	14
		  	5.5.	  	Period	  	14
	6.	  	RIGHT OF PARTICIPATION	  	14
		  	6.1.	  	Right of Participation.	  	14
		  	6.2.	  	Post-Issuance Notice	  	17
		  	6.3.	  	Excluded Transactions	  	17
		  	6.4.	  	Certain Provisions Applicable to Options, Warrants and Convertible Securities	  	18
		  	6.5.	  	Acquired Shares	  	18
		  	6.6.	  	Period	  	18
	7.	  	REGISTRATION RIGHTS	  	18
		  	7.1.	  	Demand Registration Rights for Investor Shares.	  	18
		  	7.2.	  	Piggyback Registration Rights.	  	20
		  	7.3.	  	Certain Other Provisions.	  	21
		  	7.4.	  	Indemnification and Contribution.	  	23
	8.	  	REMEDIES.	  	26

							
		  	8.1.	  	Generally	  	26
		  	8.2.	  	Deposit	  	26
	9.	  	LEGENDS.	  	26
		  	9.1.	  	Restrictive Legend	  	26
		  	9.2.	  	1933 Act Legends	  	27
		  	9.3.	  	Stop Transfer Instruction	  	27
		  	9.4.	  	Termination of 1933 Act Legend	  	27
	10.	  	AMENDMENT, TERMINATION, ETC.	  	28
		  	10.1.	  	Oral Modifications	  	28
		  	10.2.	  	Written Modifications	  	28
		  	10.3.	  	Effect of Termination	  	28
	11.	  	DEFINITIONS	  	28
		  	11.1.	  	Certain Matters of Construction	  	28
		  	11.2.	  	Definitions	  	28
	12.	  	MISCELLANEOUS.	  	35
		  	12.1.	  	Authority; Effect	  	35
		  	12.2.	  	Notices	  	35
		  	12.3.	  	Binding Effect, Etc	  	36
		  	12.4.	  	Descriptive Headings	  	36
		  	12.5.	  	Counterparts	  	37
		  	12.6.	  	Severability	  	37
	13.	  	GOVERNING LAW.	  	37
		  	13.1.	  	Governing Law	  	37
		  	13.2.	  	Consent to Jurisdiction	  	37
		  	13.3.	  	WAIVER OF JURY TRIAL	  	37
		  	13.4.	  	Exercise of Rights and Remedies	  	38

  

 ii 

 STOCKHOLDERS AGREEMENT 
 This Stockholders Agreement (the “Agreement”) is made as of February 6, 2006 by and among: 
  

	 	(i)	CRC Health Group, Inc. (f/k/a CRCA Holdings, Inc.) (the “Company”); 

  

	 	(ii)	CRC Intermediate Holdings, Inc. (“Intermediate Holdco”); 

  

	 	(iii)	CRC Health Corporation (f/k/a CRC Health Group, Inc.) (“CRC”); 

  

	 	(iv)	each of Bain Capital Fund VIII, LLC, Bain Capital VIII Coinvestment Fund, LLC, BCIP Associates III, LLC, BCIP Associates III-B, LLC, BCIP T Associates III, LLC, BCIP T Associates
III-B, LLC and BCIP Associates-G (together with their Permitted Transferees, the “Investors”); 

  

	 	(v)	RGIP, LLC and such other Persons who from time to time become party hereto by executing a counterpart signature page hereof and are designated by the Board as “Other
Investors” (together with their Permitted Transferees, the “Other Investors”); 

  

	 	(vi)	Dr. Barry Karlin and such other Persons who from time to time become party hereto by executing a counterpart signature page hereof and are designated by the Board as
“Managers” (together with their Permitted Transferees, the “Managers” and together with the Investors and the Other Investors, the “Stockholders”). 

 Recitals 
 1. On or about the date
hereof, CRCA Merger Corporation (“MergerCo”), a wholly owned subsidiary of the Company, merged with and into or will merge with and into CRC with CRC being the surviving corporation, pursuant to an Agreement and Plan of Merger dated
October 8, 2005 among the Company, MergerCo and CRC (the “Merger Agreement”). 
 2. Upon the Closing (as defined
below), the Company’s Common Stock is held as set forth on Schedule I hereto. 
 3. The parties believe that it is in the best
interests of the Company and the Stockholders to set forth their agreements on certain matters. 
 Agreement 
 Therefore, the parties hereto hereby agree as follows: 
 1. EFFECTIVENESS; DEFINITIONS. 
 1.1. Closing. This Agreement shall become effective
upon consummation of the closing under the Merger Agreement (the “Closing”). 

 1.2. Definitions. Certain terms are used in this Agreement as specifically defined
herein. These definitions are set forth or referred to in Section 12 hereof. 
 2. VOTING AGREEMENT. 
 2.1. Election of Directors. Each holder of Shares hereby agrees to cast all votes to which such holder is entitled in respect of
the Shares (other than Management Incentive Shares), whether at any annual or special meeting, by written consent or otherwise, (a) to fix the number of members of the board of directors of the Company (the “Board”) at such
number as may be specified from time to time by the Majority Investors and (b) to elect as members of the Board the Company’s Chief Executive Officer and such other individuals, if any, as shall have been nominated by the Majority
Investors. 
 2.2. Significant Transactions. Each holder of Shares agrees to cast all votes to which such holder is
entitled in respect of the Shares (other than Management Incentive Shares), whether at any annual or special meeting, by written consent or otherwise, in the same proportion as Investor Shares are voted by the Investors to approve any sale,
recapitalization, merger, consolidation, reorganization or any other transaction or series of transactions involving the Company or its subsidiaries (or all or any portion of their respective assets) in connection with, or in furtherance of, the
exercise by the Majority Investors of their rights under Section 4.2. 
 2.3. Consent to Amendment. Each holder of
Shares agrees to cast all votes to which such holder is entitled in respect of the Shares (other than Management Incentive Shares), whether at any annual or special meeting, by written consent or otherwise, in the same proportion as Investor Shares
are voted by the Majority Investors to increase the number of authorized shares of Common Stock to the extent necessary to permit the Company to comply with the provisions of its Certificate of Incorporation or any agreement to which the Company is
a party. 
 2.4. Grant of Proxy. Each holder of Shares other than the Investors hereby grants to the Investors an
irrevocable proxy coupled with an interest to vote his Shares (other than Management Incentive Shares) in accordance with his agreements contained in this Section 2, which proxy shall be valid and remain in effect until the provisions of this
Section 2 expire pursuant to Section 2.6. 
 2.5. The Company. The Company agrees not to give effect to any
action by any holder of Shares or any other Person which is in contravention of this Section 2. 
 2.6. Period.
The foregoing provisions of this Section 2 shall expire on the earlier of (a) a Change of Control, (b) a Qualified Public Offering and (c) the last date permitted by law. 
 3. TRANSFER RESTRICTIONS. No holder of Shares shall Transfer any of such Shares to any other Person except as provided in this Section 3.

  

 - 2 - 

 3.1. Permitted Transferees. 
 3.1.1 Affiliates. Any holder of Shares may Transfer any or all of such Shares to an Affiliate of such holder or to a Charitable
Organization. 
 3.1.2 Estate Planning. Any holder of Shares who is a natural Person may Transfer any or all of such
Shares (i) by gift to, or for the benefit of, any member or Members of the Immediate Family of such holder, (ii) to a trust for the benefit of such holder and/or any member or Members of the Immediate Family of such holder, or
(iii) to any other trust in respect of which such holder serves as trustee; provided, however, that the trust instrument governing such trust shall provide that such holder, as trustee, shall retain sole and exclusive control over
the voting and disposition of such Shares until the termination of this Agreement. 
 3.1.3 Upon Death. Subject to the
provisions of Section 5.1, if applicable, upon the death of any holder of Shares who is a natural Person, such Shares may be distributed by the will or other instrument taking effect at death of such holder or by applicable laws of descent and
distribution to such holder’s estate, executors, administrators and personal representatives, and then to such holder’s heirs, legatees or distributees, whether or not such recipients are Members of the Immediate Family of such holder or a
Charitable Organization. 
 3.1.4 Investors and Company. Any holder of Shares may Transfer any or all of such Shares to
(a) any Investor or (b) with the Board’s approval, the Company or any subsidiary of the Company. 
 3.1.5
Additional Permitted Transfers by the Investors. Any holder of Investor Shares may Transfer any or all of such Shares (a) to an Investor or an Affiliated Fund or (b) to its partners or members or to Affiliates of any of the
foregoing. 
 3.1.6 Additional Permitted Transfers by the Other Investors. Any holder of Other Investor Shares may
Transfer any or all of such Shares to its partners or members in connection with the termination of such holder’s legal existence. Any such transfer may be made no earlier than six months prior to the termination of the holder’s existence.

 No Transfer permitted under the terms of this Section 3.1 shall be effective unless the transferee of such Shares (each, a “Permitted
Transferee”) has delivered to the Company a written acknowledgment and agreement in form and substance reasonably satisfactory to the Company that such Shares to be received by such Permitted Transferee shall remain Investor Shares, Other
Investor Shares or Management Shares, as the case may be, and shall be subject to all of the provisions of this Agreement and that such Permitted Transferee shall be bound by, and shall be a party to, this Agreement as the holder of Investor Shares,
Other Investor Shares or Management Shares, as the case may be, hereunder; provided, however, that Shares Transferred to any director, officer or employee of, or consultant or adviser to, the Company or any of its subsidiaries by a
holder of Investor Shares shall thereafter become Management Shares hereunder; and provided further that no Transfer by any holder of Shares to a Permitted Transferee shall relieve such holder of any of its obligations hereunder.

  

 - 3 - 

 3.2. Tag Alongs, Drag Alongs, Etc. In addition to Transfers permitted under
Section 3.1, 
 (a) any holder of Investor Shares may Transfer such Shares if (i) such holder has complied with the
“tag along” provisions contained in Section 4.1 or (ii) the Majority Investors have exercised their “drag along” rights set forth in Section 4.2; and 
 (b) any holder of Shares may Transfer any or all of such Shares in accordance with the provisions, terms and conditions of
Section 4.1 and 4.2. 
 Any Shares Transferred after compliance with the terms of Section 4.1 or 4.2 shall conclusively be deemed thereafter not to
be Shares or Registrable Securities under this Agreement and not to be subject to any of the provisions hereof or entitled to the benefit of any of the provisions hereof. 
 3.3. Transfers to the Public. Subject to the provisions of Section 7.3.4, any holder of Shares may Transfer such Shares in a
Public Offering or, after the closing of the Initial Public Offering, pursuant to Rule 144, if such transfer would not result in the Relative Ownership Percentage (as defined below) of the Management Shares owned by such Manager immediately
following the effective time of such Transfer (the “Determination Time”) being less than the Relative Ownership Percentage of the Shares owned by the Investors immediately following the Determination Time. For purposes of this
Section 3.3, “Relative Ownership Percentage” means: 
 (a) with respect to the Shares held by such
Manager, a fraction (expressed as a percentage), (A) the numerator of which is the number of Shares owned by such Manager immediately following the Determination Time and (B) the denominator of which is the number of Shares purchased by or
issued to such Manager, and 
 (b) with respect to the Shares held by the Investors, a fraction (expressed as a percentage),
(A) the numerator of which is the aggregate number of Shares owned by the Investors immediately following the Determination Time and (B) the denominator of which is the aggregate number of Shares purchased by or issued to the Investors.

 3.3.1 Following the Initial Public Offering, any Investor or Manager Transferring Shares shall notify the Company following
the consummation of such Transfer of the number of Shares Transferred. Any Manager wishing to Transfer Shares pursuant to Section 3.3 shall be entitled to obtain prior to such Transfer, and rely upon, a statement from the Company, of the number
of Shares that such Manager may Transfer pursuant to this Section 3.3. 
 3.3.2 Any Shares Transferred pursuant to this
Section 3.3 shall conclusively be deemed thereafter not to be Shares or Registrable Securities under this Agreement and not to be subject to any of the provisions hereof or entitled to the benefit of any of the provisions hereof. 
  

 - 4 - 

 3.4. Transfers Pursuant to Section 5. Management Shares may be transferred
pursuant to the terms of Section 5. Any Shares Transferred to the Company pursuant to Section 5 shall conclusively be deemed thereafter not to be Shares or Registrable Securities under this Agreement and not to be subject to any of the
provisions hereof or entitled to the benefit of any of the provisions hereof. Any Shares Transferred to the Investors pursuant to Section 5 shall conclusively be deemed thereafter to be Investor Shares and Registrable Securities under this
Agreement and shall be subject to, and entitled to the benefit of, the provisions hereto. 
 3.5. Impermissible
Transfer. Any attempted Transfer of Shares not permitted under the terms of this Section 3 shall be null and void, and the Company shall not in any way give effect to any such impermissible Transfer. 
 3.6. Period. The foregoing provisions of this Section 3 shall expire upon the earlier of (a) a Change of Control and
(b) the later of (i) the fifth anniversary of the first Public Offering in which the Investors sell shares and (ii) the date on which the Relative Ownership Percentage of the Investors is less than 50%. 
 4. INVESTOR TRANSFER RIGHTS; “TAG ALONG” AND “DRAG ALONG” RIGHTS. 
 4.1. Tag Along. If one or more holders of Investor Shares (each such holder, a “Prospective Selling Investor”)
proposes to Transfer any such Shares to any Prospective Buyer in a transaction subject to Section 3.2(a)(i), then as required by Section 3.2(a)(i): 
 4.1.1 Notice. The Prospective Selling Investors shall deliver a written notice (the “Tag Along Notice”) to each
other holder of Shares (each, a “Tag Along Holder”) at least ten business days prior to such proposed Transfer. The Tag Along Notice shall include: 
 (a) The principal terms of the proposed Sale insofar as it relates to such Shares, including (i) the number and class of the Shares
to be purchased from the Prospective Selling Investors, (ii) with respect to each class of Shares to be purchased from the Prospective Selling Investors, the fraction(s) expressed as a percentage, determined by dividing the number of Shares of
such class to be purchased from the Prospective Selling Investors by the total number of Investor Shares of such class purchased by the Investors (the “Tag Along Sale Percentage”), (iii) the maximum and minimum per share
purchase price and (iv) the name and address of the Prospective Buyer; and 
 (b) An invitation to each Tag Along Holder
to make an offer to include in the proposed Sale to the applicable Prospective Buyer an additional number of Shares of the applicable class held by such Tag Along Holder (not in any event to exceed in the case of a Tag Along Holder and all of his
Permitted Transferees the Tag Along Sale Percentage of the total number of Shares of the applicable class purchased by such Tag Along Holder), on the same terms and conditions (subject to Section 4.3.4 in the case of Options, Warrants and
Convertible Securities), with respect to each Share Sold, as the Prospective Selling Investors shall Sell each of their Shares. 
  

 - 5 - 

 4.1.2 Exercise. Within ten business days after the effectiveness of the Tag Along
Notice, each Tag Along Holder desiring to make an offer to include issued and outstanding Shares in the proposed Sale (each a “Participating Seller” and, together with the Prospective Selling Investors, collectively, the
“Tag Along Sellers”) shall furnish a written notice (the “Tag Along Offer”) to the Prospective Selling Investors offering to include an additional number of Shares of the applicable class (not in any event to exceed
the Tag Along Sale Percentage of the total number of Shares of the applicable class purchased by such Participating Seller) which such Participating Seller desires to have included in the proposed Sale. Each Tag Along Holder who does not accept the
Prospective Selling Investors’ invitation to make an offer to include Shares in the proposed Sale shall be deemed to have waived all of his rights with respect to such Sale, and the Tag Along Sellers shall thereafter be free to Sell to the
Prospective Buyer, at a per share price no greater than the maximum per share price set forth in the Tag Along Notice and on other principal terms which are not materially more favorable to the Tag Along Sellers than those set forth in the Tag Along
Notice, without any further obligation to such non-accepting Tag Along Holder. 
 4.1.3 Irrevocable Offer. The offer of
each Participating Seller contained in his Tag Along Offer shall be irrevocable, and, to the extent such offer is accepted, such Participating Seller shall be bound and obligated to Sell in the proposed Sale on the same terms and conditions, with
respect to each Share Sold (subject to Section 4.3.4 in the case of Options, Warrants and Convertible Securities), as the Prospective Selling Investors, up to such number of Shares as such Participating Seller shall have specified in his Tag
Along Offer; provided, however, that if the principal terms of the proposed Sale change with the result that the per share price shall be less than the minimum per share price set forth in the Tag Along Notice or the other principal
terms shall be materially less favorable to the Tag Along Sellers than those set forth in the Tag Along Notice, each Participating Seller shall be permitted to withdraw the offer contained in his Tag Along Offer and shall be released from his
obligations thereunder. 
 4.1.4 Reduction of Shares Sold. The Prospective Selling Investors shall attempt to obtain
the inclusion in the proposed Sale of the entire number of Shares which each of the Tag Along Sellers requested to have included in the Sale (as evidenced in the case of the Prospective Selling Investors by the Tag Along Notice and in the case of
each Participating Seller by such Participating Seller’s Tag Along Offer). In the event the Prospective Selling Investors shall be unable to obtain the inclusion of such entire number of Shares in the proposed Sale, the number of Shares of each
class to be sold in the proposed Sale shall be allocated among the Tag Along Sellers in proportion, as nearly as practicable, to the respective number of Shares of such class purchased by each Tag Along Seller. 
 4.1.5 Additional Compliance. If (a) prior to consummation, the terms of the proposed Sale shall change with the result that
the per share price to be paid in such 

  

 - 6 - 

 
proposed Sale shall be greater than the maximum per share price set forth in the Tag Along Notice or the other principal terms of such proposed Sale shall be
materially more favorable to the Tag Along Sellers than those set forth in the Tag Along Notice, the Tag Along Notice shall be null and void, and it shall be necessary for a separate Tag Along Notice to be furnished, and the terms and provisions of
this Section 4.1 separately complied with, in order to consummate such proposed Sale pursuant to this Section 4.1; provided, however, that in the case of such a separate Tag Along Notice, the applicable period to which
reference is made in Sections 4.1.1 and 4.1.2 shall be five business days and (b) the Prospective Selling Investors have not completed the proposed Sale by the end of the 180th day following the date of the effectiveness of the Tag Along
Notice, each Participating Seller shall be released from his obligations under his Tag Along Offer, the Tag Along Notice shall be null and void, and it shall be necessary for a separate Tag Along Notice to be furnished, and the terms and provisions
of this Section 4.1 separately complied with, in order to consummate such proposed Sale pursuant to this Section 4.1, unless the failure to complete such proposed Sale resulted from any failure by any Participating Seller to comply with
the terms of this Section 4. 
 4.2. Drag Along. Each holder of Shares of a class hereby agrees, if requested by
the Majority Investors, to Sell the same percentage (the “Drag Along Sale Percentage”) of such Shares, directly or indirectly, to a Prospective Buyer in the manner and on the terms set forth in this Section 4.2 in connection
with the Sale by one or more holders of Investor Shares (each such holder, a “Prospective Selling Investor”) of the Drag Along Sale Percentage of the total number of Investor Shares of a class held by all holders of Investor Shares
to the Prospective Buyer. 
 4.2.1 Exercise. If the Majority Investors elect to exercise their rights under this
Section 4.2, the Prospective Selling Investors shall furnish a written notice (the “Drag Along Notice”) to each other holder of Shares. The Drag Along Notice shall set forth the principal terms of the proposed Sale insofar as
it relates to such Shares including (i) the number and class of Shares to be acquired from the Prospective Selling Investors, (ii) the Drag Along Sale Percentage applicable to such class, (iii) the per share consideration applicable
to such class to be received in the proposed Sale of shares of a class and (iv) the name and address of the Prospective Buyer. If the Prospective Selling Investors consummate the proposed Sale to which reference is made in the Drag Along
Notice, each other holder of Shares (each a “Participating Seller”, and, together with the Prospective Selling Investors, collectively, the “Drag Along Sellers”) shall be bound and obligated to Sell the Drag Along
Sale Percentage of his Shares of such class in the proposed Sale on the same terms and conditions, with respect to each Share Sold (subject to Section 4.3.4 in the case of Options and Warrants), as the Prospective Selling Investors shall Sell
each Investor Share of such class in the Sale (subject to Section 4.3.4 in the case of Options and Warrants). If at the end of the 180th day following the date of the effectiveness of the Drag Along Notice the Prospective Selling Investors have
not completed the proposed Sale, the Drag Along Notice shall be null and void, each Participating Seller shall be released from his obligation under the Drag Along Notice and it shall be necessary for a separate Drag Along Notice to be furnished and
the terms and provisions of this Section 4.2 separately complied with, in order to consummate such proposed Sale pursuant to this Section 4.2. 
  

 - 7 - 

 4.3. Miscellaneous. The following provisions shall be applied to any proposed Sale
to which Section 4.1 or 4.2 applies: 
 4.3.1 Certain Legal Requirements. In the event the consideration to be
paid in exchange for Shares in a proposed Sale pursuant to Section 4.1 or Section 4.2 includes any securities, and the receipt thereof by a Participating Seller would require under applicable law (a) the registration or qualification
of such securities or of any person as a broker or dealer or agent with respect to such securities or (b) the provision to any Tag Along Seller or Drag Along Seller of any information regarding the Company, such securities or the issuer
thereof, such Participating Seller shall not have the right to Sell Shares in such proposed Sale. In such event, the Prospective Selling Investors shall have the right, but not the obligation, to cause to be paid to such Participating Seller in lieu
thereof, against surrender of the Shares (in accordance with Section 4.3.6 hereof) which would have otherwise been Sold by such Participating Seller to the Prospective Buyer in the proposed Sale, an amount in cash equal to the Fair Market Value
of such Shares as of the date such securities would have been issued in exchange for such Shares. 
 4.3.2 Further
Assurances. Each Participating Seller, whether in his capacity as a Participating Seller, stockholder, officer or director of the Company, or otherwise, shall take or cause to be taken all such actions as may be necessary or reasonably desirable
in order expeditiously to consummate each Sale pursuant to Section 4.1 or Section 4.2 and any related transactions, including, without limitation, executing, acknowledging and delivering consents, assignments, waivers and other documents
or instruments; furnishing information and copies of documents; filing applications, reports, returns, filings and other documents or instruments with governmental authorities; and otherwise cooperating with the Prospective Selling Investors and the
Prospective Buyer; provided, however, that Participating Sellers shall be obligated to become liable in respect of any representations, warranties, covenants, indemnities or otherwise to the Prospective Buyer solely to the extent
provided in the immediately following sentence and provided, further, that no holder of Management Incentive Shares shall be obligated to cast votes in respect of such Management Incentive Shares in connection with any such
transaction. Without limiting the generality of the foregoing, each Participating Seller agrees to execute and deliver such agreements as may be reasonably specified by the Prospective Selling Investors to which such Prospective Selling Investors
will also be party, including, without limitation, agreements to (a) (i) make individual representations, warranties, covenants and other agreements as to the unencumbered title to its Shares and the power, authority and legal right to
Transfer such Shares and the absence of any Adverse Claim with respect to such Shares and (ii) be liable without limitation as to such representations, warranties, covenants and other agreements and (b) be liable (whether by purchase price
adjustment, indemnity payments or otherwise) in respect of representations, warranties, covenants and agreements in respect of the Company and its subsidiaries; provided, however, that the aggregate amount of liability described in
this clause (b) in connection with any Sale of Shares shall not exceed the lesser of (i) such Participating Seller’s pro rata portion of 

  

 - 8 - 

 
any such liability, to be determined in accordance with such Participating Seller’s portion of the total number of Shares included in such Sale or
(ii) the proceeds to such Participating Seller in connection with such Sale. 
 4.3.3 Sale Process. The Investors
shall, in their sole discretion, decide whether or not to pursue, consummate, postpone or abandon any proposed Sale and the terms and conditions thereof. No Investor or any Affiliate of any Investor shall have any liability to any other holder of
Shares arising from, relating to or in connection with the pursuit, consummation, postponement, abandonment or terms and conditions of any proposed Sale except to the extent such Investor shall have failed to comply with the provisions of this
Section 4. 
 4.3.4 Treatment of Options, Warrants and Convertible Securities. Each Participating Seller agrees
that to the extent he desires to include Options, Warrants or Convertible Securities in any Sale of Shares pursuant to Section 4, he shall be deemed to have exercised, converted or exchanged such Options, Warrants or Convertible Security
immediately prior to the closing of such Sale to the extent necessary to Sell Common Stock to the Prospective Buyer, except to the extent permitted under the terms of any such Option, Warrant or Convertible Security and agreed by the Prospective
Buyer. If any Participating Seller shall Sell Options, Warrants or Convertible Securities in any Sale pursuant to Section 4, such Participating Seller shall receive in exchange for such Options, Warrants or Convertible Securities consideration
equal to the amount (if greater than zero) determined by multiplying (a) the purchase price per share of Common Stock received by the holders of the Prospective Selling Investors in such Sale less the exercise price, if any, per share of such
Option, Warrant or Convertible Security by (b) the number of shares of Common Stock issuable upon exercise, conversion or exchange of such Option, Warrant or Convertible Security (to the extent exercisable, convertible or exchangeable at the
time of such Sale), subject to reduction for any tax or other amounts required to be withheld under applicable law. 
 4.3.5
Expenses. All reasonable costs and expenses incurred by the Prospective Selling Investors or the Company in connection with any proposed Sale pursuant to this Section 4 (whether or not consummated), including without limitation all
attorneys fees and expenses, all accounting fees and charges and all finders, brokerage or investment banking fees, charges or commissions, shall be paid by the Company. The reasonable fees and expenses of a single legal counsel representing any or
all of the other Tag Along Sellers or Drag Along Sellers in connection with any proposed Sale pursuant to this Section 4 (whether or not consummated) shall be paid by the Company. Any other costs and expenses incurred by or on behalf of any or
all of the other Tag Along Seller(s) or Drag Along Seller(s) in connection with any proposed Sale pursuant to this Section 4 (whether or not consummated) shall be borne by such Tag Along Seller(s) or Drag Along Seller(s). 
 4.3.6 Closing. The closing of a Sale to which Section 4.1 or 4.2 applies shall take place at such time and place as the
Prospective Selling Investors shall specify by notice to each Participating Seller. At the closing of such Sale, each Participating Seller shall 

  

 - 9 - 

 
deliver the certificates evidencing the Shares to be Sold by such Participating Seller, duly endorsed, or with stock (or equivalent) powers duly endorsed,
for transfer with signature guaranteed, free and clear of any liens or encumbrances, with any stock (or equivalent) transfer tax stamps affixed, against delivery of the applicable consideration. 
 4.4. Period. The foregoing provisions of this Section 4 shall expire on the earlier of (a) a Change of Control or
(b) the closing of a Qualified Public Offering. 
 5. OPTIONS TO PURCHASE MANAGEMENT SHARES. 
 5.1. Call Options. Except as the Company may otherwise agree in writing with any Manager with respect to Shares held by such
Manager or originally issued to such Manager but held by one or more direct or indirect Permitted Transferees (collectively, the “Management Call Group”), upon any termination of the employment by the Company and its subsidiaries of
any Manager (by the Company, such Manager or otherwise), the Company shall have the right to purchase for cash all or any portion of the Management Shares held by the Management Call Group on the following terms (the “Management Call
Option”): 
 5.1.1 Rollover Option Shares. The Company may purchase all or any portion of the Rollover Option
Shares held by such Manager (or his direct or indirect Permitted Transferees, if applicable) at a per share price equal to the Fair Market Value of such Shares as determined in Section 5.1.3. 
 5.1.2 Other. For all Purchased Management Shares which are not Rollover Option Shares, the following terms shall apply: 

(a) Termination for Cause. If such termination is the result of termination of such holder’s employment by the Company or
its subsidiary for Cause, then the Company may purchase all or any portion of the Purchased Management Shares held by such Manager (or his direct or indirect Permitted Transferees, if applicable) at a per Share price equal to the lesser of the Cost
or the Fair Market Value of such Shares as determined in Section 5.1.3, provided, however, that the portion of such Shares as is required by California Corporations Code Regulations 260.140.4(k)(2) and 260.140.42(h)(2) to be
repurchased at Fair Market Value, may only be repurchased at the Fair Market Value of such Shares as determined as of the date of the effectiveness of the applicable termination of employment. 
 (b) Death or Disability. If such termination is the result of the death or disability of such Manager, then the Company may
purchase all or any portion of the Purchased Management Shares held by such Manager (or his direct or indirect Permitted Transferees, if applicable) at a per Share price equal to the Fair Market Value of such Shares as determined in
Section 5.1.3. 
 (c) Termination by Manager. If such termination is the result of termination by a Manager (but
not by the Company) other than by reason of the Manager’s death or disability and other than in circumstances where the Company or its subsidiaries 

  

 - 10 - 

 
would have grounds to terminate such Manager for Cause, then the Company may purchase all or any portion of the Purchased Management Shares held by such
Manager (or his direct or indirect Permitted Transferees, if applicable) at a per Share price equal to the Fair Market Value of such Shares as determined in Section 5.1.3. 
 (d) Termination by the Company Not for Cause. If such termination is the result of termination by the Company and such
termination is not for Cause, then the Company may purchase all or any portion of the Purchased Management Shares held by such Manager (or his direct or indirect Permitted Transferees, if applicable) at a per Share price equal to the Fair
Market Value of such Shares as determined in Section 5.1.3, but the Company may not purchase any of the Management Incentive Shares held by such Manager. 
 5.1.3 Determination Date. 
 (a) In the case of Shares other than Option Shares, the purchase price per Share shall be determined as of the date on which the Management Call Notice (as defined below) is delivered. 
 (b) In the case of Option Shares that are subject to Section 5.1.2(c) (and are not Management Incentive Shares), the purchase price
per Share shall be determined as of the later of (i) the 181st day after the exercise of the applicable Option
and (ii) the date on which the Management Call Notice (as defined below) is delivered. 
 (c) In the case of Option
Shares that are subject to Section 5.1.2 (a), (b) or (c) (and are not Management Incentive Shares), the purchase price per Share shall be determined as of the date on which the Management Call Notice (as defined below) is
delivered. 
 (d) In the case of Management Incentive Shares (which are subject to Section 5.1.2(a), (b) or (c)),
the purchase price per Share shall be determined as of the date of effectiveness of the applicable termination of employment. 
 5.1.4 Notices, Etc. Any Management Call Option may be exercised by delivery of written notice thereof (the “Management Call Notice”) to all members of the applicable Management Call Group from whom the Company has
elected to purchase Shares no later than the Management Call Notice Date. The Management Call Notice shall state that the Company has elected to exercise the Management Call Option, the number of Shares with respect to which the Management Call
Option is being exercised and the price or date for determining the price of such shares. For purposes of this Section 5, the “Management Call Notice Date” shall mean: 
  

 - 11 - 

			
	 Type of Shares
	  	 Management Call Notice Date

	Management Incentive Shares (subject to Sections 5.1.2(a), (b) or (c) above)	  	No later than 90 days after the effectiveness of the applicable termination of employment or, for Management Incentive Shares that are Option Shares, if later, 90 days after the exercise of the
Option to which such Option Shares relate.
		
	Management Shares that are not Management Incentive Shares or Rollover Option Shares	  	No later than 180 days after the effectiveness of the applicable termination of employment, or, with respect to Option Shares, if later, 180 days after the exercise of the Option to which such
Option Shares relate.
		
	Rollover Option Shares	  	No later than 360 days after the effectiveness of the applicable termination of employment or, if later, 360 days after the exercise of the Option to which such Rollover Option Shares
relate.

 5.1.5 Vesting. The rights of the Company and the Investors to purchase
Management Shares under this Section 5 are in addition to, and do not modify, any vesting requirements that may be included in the terms of any Management Shares. 
 5.2. Closing. 
 5.2.1 The closing of any purchase and sale of Management Shares pursuant to this Section 5 shall take place as soon as reasonably practicable, and in any event not later than 30 days after delivery of the Management Call Notice or, in
the case of Option Shares, if later, 30 days after the determination of the applicable purchase price in accordance with Section 5.1.3 (provided, that such time shall be extended as necessary to comply with requirements of the
Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, or other applicable legal requirements) at the principal office of the Company, or at such other time and location as the parties to such purchase may mutually determine.
Notwithstanding anything to the contrary in this Section 5.2.1, the closing of any purchase and sale of any Management Incentive Shares pursuant to this Section 5 shall take place not later than 90 days after the later of
(i) effectiveness of the applicable termination of employment or (ii) exercise of the Option to which such Management Incentive Shares relate. 
 5.2.2 At the closing of any purchase and sale of Management Shares following the exercise of any Management Call Option, the holders of Shares to be sold shall deliver to the Company a certificate or certificates
representing the Shares to be purchased by the Company duly endorsed, or with stock (or equivalent) powers duly endorsed, for transfer with signature guaranteed, free and clear of any lien or encumbrance, with any necessary stock (or equivalent)
transfer tax stamps affixed, and 

  

 - 12 - 

 
the Company shall pay to such holder by certified or bank check or wire transfer of immediately available federal funds the purchase price of the Shares
being purchased by the Company. The delivery of a certificate or certificates for Shares by any Person selling Shares pursuant to any Management Call Option shall be deemed a representation and warranty by such Person that: (i) such Person has
full right, title and interest in and to such Shares; (ii) such Person has all necessary power and authority and has taken all necessary action to sell such Shares as contemplated; (iii) such Shares are free and clear of any and all liens
or encumbrances and (iv) there is no Adverse Claim with respect to such Shares. 
 5.2.3 If (i) any payment of cash
is required upon the purchase of Management Shares (other than Rollover Option Shares and Management Incentive Shares, which may only be purchased for cash) by the Company upon the exercise of any Management Call Option or (ii) any payment on a
promissory note issued under this Section 5.2.3 comes due, and, in either case such payment would constitute, result in or give rise to any breach or violation of, or any default or right or cause of action under, any agreement by which the
Company or any of its subsidiaries is, from time to time, a party, then: 
 (a) in the case of a cash payment due at a
closing of any purchase of Management Shares (other than Rollover Option Shares and Management Incentive Shares, which may only be purchased for cash) by the Company upon the exercise of any Management Call Option, the Company will issue a
promissory note in the aggregate principal amount of such payment, the principal amount of which note will be due and payable on demand (subject to subsection 5.2.3(c) below) and interest will accrue thereon at a rate equal to the applicable federal
rate, and 
 (b) in the case of a cash payment in respect of a promissory note issued under this Section 5.2.3,
notwithstanding any of the provisions of such note, including without limitation, the stated maturity of such note and the stated date on which interest payments are due, such payment will not become due and payable until such time as such payment
can be made without violating any such agreement. 
 (c) Notwithstanding the terms of any promissory note issued pursuant to
this Section 5.2, the Company must pay off the promissory note at the earlier of (i) a Sale Transaction, (ii) five (5) Business Days after the date at which a cash payment paying off such promissory note could be made without
resulting in or giving rise to any breach or violation of, or any default or right or cause of action under, any agreement by which the Company or any of its subsidiaries is, from time to time, a party, (iii) the date on which any cash dividend
or distribution is made in respect of Shares, and (iv) the 91st day after February 1, 2016, the final
maturity date of the Senior Subordinated Notes of CRC. At such time, the Company shall promptly notify the holder of such promissory note and make a payment on each such promissory note. If more than one such promissory note is outstanding at the
time of payment, payment shall be made to the holders of all such promissory notes on a pro rata basis. 
  

 - 13 - 

 5.3. Investor Call Option. If the Company shall elect not to purchase pursuant to
Section 5.1 any or all Management Shares held by a Manager or originally issued to such Manager but held by one or more Permitted Transferees, the Company shall notify the Investors and the Investors may purchase any or all of the remaining
Management Shares held by such Persons for the purchase price identified in Section 5.1; provided, that nothing in this Section 5.3 will operate to extend the time within which the Management Call Notice may be delivered pursuant to
Section 5.1.4 hereof. The right to purchase such Shares shall be allocated pro rata among the Investors (unless the Investors otherwise agree). 
 5.4. Acknowledgment. Each holder of Management Shares acknowledges and agrees that neither the Company nor any Person directly or indirectly affiliated with the Company (in each case whether as a director,
officer, manager, employee, agent or otherwise) shall have any duty or obligation to affirmatively disclose to him, and he shall not have any right to be advised of, any material information regarding the Company or otherwise at any time prior to,
upon, or in connection with any termination of his employment by the Company and its subsidiaries upon the exercise of any Management Call Option or any purchase of the Shares in accordance with the terms hereof. 
 5.5. Period. The foregoing provisions of this Section 5 shall expire with respect to any Management Share upon the earlier of
(a) a Change of Control and (b) the closing of a Qualified Public Offering. 
 6. RIGHT OF PARTICIPATION. The Company shall not
issue or sell any shares of any of its capital stock or any securities convertible into or exchangeable for any shares of its capital stock, issue or grant any options or warrants for the purchase of, or enter into any agreements providing for the
issuance (contingent or otherwise) of, any of its capital stock or any stock or securities convertible into or exchangeable for any shares of its capital stock, in each case, to any Investor or Affiliated Fund (each an “Issuance” of
“Subject Securities”), except in compliance with the provisions of Section 6.1 or 6.2. 
 6.1. Right
of Participation. 
 6.1.1 Offer. Not fewer than fifteen days prior to the consummation of an Issuance, a notice
(the “Participation Notice”) shall be furnished by the Company to each holder of Investor Shares, Other Investor Shares, Rollover Options and/or Purchased Management Shares (the “Participation Offerees”). The
Participation Notice shall include: 
 (a) The principal terms of the proposed Issuance, including, without limitation,
(i) the amount and kind of Subject Securities to be included in the Issuance, (ii) the number of Equivalent Shares represented by such Subject Securities (if applicable), (iii) the percentage of the total number of Equivalent Shares
outstanding as of immediately prior to giving effect to such Issuance which the number of Equivalent Shares held by such Participation Offeree constitutes (the “Participation Portion”), (iv) the maximum and minimum price
(including, without limitation, if applicable, the maximum and minimum Price Per Equivalent Share) per unit of the Subject Securities and (v) the name and address of the Investor or Affiliated Fund to whom the Subject Securities will be issued
(the “Prospective Subscriber”); and 
  

 - 14 - 

 (b) An offer by the Company to issue, at the option of each Participation Offeree, to
such Participation Offeree such portion of the Subject Securities to be included in the Issuance as may be requested by such Participation Offeree (not to exceed the Participation Portion of the total amount of Subject Securities to be included in
the Issuance), on the same economic terms and conditions, with respect to each unit of Subject Securities issued to the Participation Offerees, as each of the Prospective Subscribers shall be issued units of Subject Securities. 
 6.1.2 Exercise. 
 (a) General. Each Participation Offeree desiring to accept the offer contained in the Participation Notice shall send a written commitment to the Company within fifteen days after the effectiveness of the
Participation Notice specifying the amount of Subject Securities (not in any event to exceed the Participation Portion of the total amount of Subject Securities to be included in the Issuance) which such Participation Offeree desires to be issued
(each a “Participating Buyer”). Each Participation Offeree who has not so accepted such offer shall be deemed to have waived all of his rights with respect to the Issuance, and the Company shall thereafter be free to issue Subject
Securities in the Issuance to the Prospective Subscriber and any Participating Buyers, at a price no less than the minimum price set forth in the Participation Notice and on other principal terms not substantially more favorable to the
Prospective Subscriber than those set forth in the Participation Notice, without any further obligation to such non-accepting Participation Offerees. If, prior to consummation, the terms of such proposed Issuance shall change with the result that
the price shall be less than the minimum price set forth in the Participation Notice or the other principal terms shall be substantially more favorable to the Prospective Subscriber than those set forth in the Participation Notice, it shall be
necessary for a separate Participation Notice to be furnished, and the terms and provisions of this Section 6.1 separately complied with, in order to consummate such Issuance pursuant to this Section 6.1. 
 (b) Irrevocable Acceptance. The acceptance of each Participating Buyer shall be irrevocable except as hereinafter provided, and
each such Participating Buyer shall be bound and obligated to acquire in the Issuance on the same terms and conditions, with respect to each unit of Subject Securities issued, as the Prospective Subscriber, such amount of Subject Securities as such
Participating Buyer shall have specified in such Participating Buyer’s written commitment. 
 (c) Time
Limitation. If at the end of the 180th day following the date of the effectiveness of the Participation Notice the Company has not completed the Issuance, each Participating Buyer shall be released from his obligations under the written
commitment, the Participation Notice shall be null and void, and it shall be necessary for a separate Participation Notice to be furnished, and the terms and provisions of this Section 6.1 separately complied with, in order to consummate such
Issuance pursuant to this Section 6.1. 
  

 - 15 - 

 6.1.3 Other Securities. The Company may condition the participation of the
Participation Offerees in an Issuance upon the purchase by such Participation Offerees of any securities (including, without limitation, debt securities) other than Subject Securities (“Other Securities”) in the event that the
participation of the Prospective Subscriber in such Issuance is so conditioned. In such case, each Participating Buyer shall acquire in the Issuance, together with the Subject Securities to be acquired by it, Other Securities in the same proportion
to the Subject Securities to be acquired by it as the proportion of Other Securities to Subject Securities being acquired by the Prospective Subscriber in the Issuance, on the same terms and conditions, as to each unit of Subject Securities and
Other Securities issued to the Participating Buyers, as the Prospective Subscriber shall be issued units of Subject Securities and Other Securities. 
 6.1.4 Certain Legal Requirements. In the event that the participation in the Issuance by a holder of Shares as a Participating Buyer would require under applicable law (i) the registration or qualification
of such securities or of any person as a broker or dealer or agent with respect to such securities or (ii) the provision to any participant in the Sale of any information regarding the Company or the securities, such holder of Shares shall not
have the right to participate in the Issuance. Without limiting the generality of the foregoing, it is understood and agreed that the Company shall not be under any obligation to effect a registration of such securities under the Securities Act or
similar state statutes. 
 6.1.5 Further Assurances. Each Participation Offeree and each Stockholder to whom the Shares
held by such Participation Offeree were originally issued, shall, whether in his capacity as a Participating Buyer, Stockholder, officer or director of the Company, or otherwise, take or cause to be taken all such reasonable actions as may be
necessary or reasonably desirable in order expeditiously to consummate each Issuance pursuant to this Section 6.1 and any related transactions, including, without limitation, executing, acknowledging and delivering consents, assignments,
waivers and other documents or instruments; filing applications, reports, returns, filings and other documents or instruments with governmental authorities; and otherwise cooperating with the Company and the Prospective Subscriber. Without limiting
the generality of the foregoing, each such Participating Buyer and Stockholder agrees to execute and deliver such subscription and other agreements specified by the Company to which the Prospective Subscriber will be party. 
 6.1.6 Expenses. All reasonable costs and expenses incurred by the holders of Investor Shares or the Company in connection with any
proposed Issuance of Subject Securities (whether or not consummated), including without limitation all attorney’s fees and charges, all accounting fees and charges and all finders, brokerage or investment banking fees, charges or commissions,
shall be paid by the Company. The reasonable fees and expenses of a single legal counsel representing any or all of the other holders of Shares in connection with such proposed Issuance of Subject Securities (whether or not 

  

 - 16 - 

 
consummated) shall be paid by the Company. Any other costs and expenses incurred by or on behalf of any other holder of Shares in connection with such
proposed Issuance of Subject Securities (whether or not consummated) shall be borne by such holder. 
 6.1.7 Closing.
The closing of an Issuance pursuant to Section 6.1 shall take place at such time and place as the Company shall specify by notice to each Participating Buyer. At the Closing of any Issuance under this Section 6.1.7, each Participating
Buyer shall be delivered the notes, certificates or other instruments evidencing the Subject Securities (and, if applicable, Other Securities) to be issued to such Participating Buyer, registered in the name of such Participating Buyer or his
designated nominee, free and clear of any liens or encumbrances, with any transfer tax stamps affixed, against delivery by such Participating Buyer of the applicable consideration. 
 6.2. Post-Issuance Notice. Notwithstanding the notice requirements of Sections 6.1.1 and 6.1.2, the Company may proceed with any
Issuance prior to having complied with the provisions of Section 6.1; provided that the Company shall: 
 (a)
provide to each holder of Shares who would have been a Participation Offeree in connection with such Issuance (i) with prompt notice of such Issuance and (ii) the Participation Notice described in Section 6.1.1 in which the actual
price per unit of Subject Securities (and, if applicable, actual Price Per Equivalent Share) shall be set forth; and 
 (b)
offer to issue to such holder of Shares such number of securities of the type issued in the Issuance as may be requested by such holder of Shares (not to exceed the Participation Portion that such holder of Shares would have been entitled to
pursuant to Section 6.1 multiplied by the sum of (a) the number of Subject Securities included in the Issuance and (b) the aggregate number of shares issued pursuant to this Section 6.2 with respect to such Issuance) on the same
economic terms and conditions with respect to such securities as the subscribers in the Issuance received; and 
 (c) keep
such offer open for a period of ten business days, during which period, each such holder may accept such offer by sending a written acceptance to the Issuer committing to purchase an amount of such securities (not in any event to exceed the
Participation Portion that such holder would have been entitled to pursuant to Section 6.1 multiplied by the sum of (a) the number of Subject Securities included in such issuance and (b) the aggregate number of shares issued pursuant
to this Section 6.2 with respect to such Issuance). 
 6.3. Excluded Transactions. Notwithstanding the preceding
provisions of this Section 6, the preceding provisions of this Section 6 shall not restrict: 
 6.3.1 Any Issuance
of Stock upon the exercise or conversion of any Stock, Options, Warrants or Convertible Securities outstanding on the date hereof or Issued after the date hereof in compliance with the provisions of this Section 6;. 
  

 - 17 - 

 6.3.2 Any Issuance of shares of Stock, Options, Warrants or Convertible Securities to
officers, employees, directors or consultants of the Company or its subsidiaries in connection with such Person’s employment or consulting arrangements with the Company or its subsidiaries; 
 6.3.3 Any Issuance of shares of Stock, Options, Warrants or Convertible Securities in connection with (i) any business combination or
acquisition transaction involving the Company or any of its subsidiaries, (ii) any joint venture or strategic partnership or (iii) the incurrence or guarantee of indebtedness by the Company or any of its subsidiaries; 
 6.3.4 Any Issuance of Stock pursuant to a Public Offering; 
 6.3.5 The Issuance of Shares to the Investors, Other Investors and Managers in connection with the Closing; or 
 6.3.6 Any Issuance of shares of Stock in connection with any stock split, stock dividend, stock combination or stock reclassification.

 6.4. Certain Provisions Applicable to Options, Warrants and Convertible Securities. In the event that the Issuance
of Subject Securities shall result in any increase in the number of shares of Common Stock issuable upon exercise, conversion or exchange of any Options, Warrants or Convertible Securities, the number of shares (or Equivalent Shares, if applicable)
of Subject Securities (and Other Securities, if applicable) which the holders of such Options, Warrants or Convertible Securities, as the case may be, shall be entitled to purchase pursuant to Section 6.1, if any, shall be reduced, share for
share, by the amount of any such increase. 
 6.5. Acquired Shares. Any Subject Securities constituting Common Stock
acquired by any holder of Shares pursuant to this Section 6 shall be deemed for all purposes hereof to be Investor Shares, Other Investor Shares or Management Shares hereunder of like kind with the Shares then held by the acquiring holder.

 6.6. Period. The foregoing provisions of this Section 6 shall expire on the earlier of (a) a Change of
Control or (b) the closing of the Initial Public Offering. 
 7. REGISTRATION RIGHTS. The Company will perform and comply, and
cause each of its subsidiaries to perform and comply, with such of the following provisions as are applicable to it. Each holder of Shares will perform and comply with such of the following provisions as are applicable to such holder. 
 7.1. Demand Registration Rights for Investor Shares. 
 7.1.1 General. One or more holders of Investor Shares representing at least 25% of the total amount of Investor Shares then
outstanding (“Initiating Investors”), by notice to the Company specifying the intended method or methods of disposition, may request that the Company effect the registration under the Securities Act for a Public Offering of 

  

 - 18 - 

 
all or a specified part of the Registrable Securities held by such Initiating Investors (for purposes of this Agreement, “Registrable Investor
Securities” shall mean Registrable Securities constituting Investor Shares). The Company will then use its best efforts to effect the registration under the Securities Act of the Registrable Securities which the Company has been requested
to register by such Initiating Investors together with all other Registrable Securities which the Company has been requested to register pursuant to Section 7.2 or by other holders of Registrable Investor Securities by notice delivered to the
Company within 20 days after the Company has given the notice required by Section 7.2.1 (which request shall specify the intended method of disposition of such Registrable Securities), all to the extent requisite to permit the disposition (in
accordance with the intended methods thereof as aforesaid) of the Registrable Securities which the Company has been so requested to register; provided, however, that the Company shall not be obligated to take any action to effect any
such registration pursuant to this Section 7.1.1: 
 (a) Upon the request of the Company, provided that the Company
shall be entitled to make such request only once per any 365 day period, in which case the Company may delay such registration until the later of (i) the 30th day following the effective date of any registration statement pertaining to an
underwritten public offering of securities of the Company for its own account (other than a Rule 145 Transaction, or a registration relating solely to employee benefit plans) or (ii) the expiration of any lock-up agreement between the Investors
or the Company and the underwriter; or 
 (b) On any form other than Form S-3 (or any successor form) if the Company has
previously effected three or more registrations of Registrable Securities under this Section 7.1.1 on any form other than Form S-3 (or any successor form); provided, however, that no registrations of Registrable Securities which
shall not have become and remained effective in accordance with the provisions of this Section 7 and no registrations of Registrable Securities pursuant to which the Initiating Investors and all other holders of Registrable Investor Securities
joining therein are not able to include at least 90% of the Registrable Securities which they desired to include, shall be included in the calculation of numbers of registrations contemplated by this clause (b). 
 7.1.2 Form. Except as otherwise provided above, each registration requested pursuant to Section 7.1.1 shall be effected by the
filing of a registration statement on Form S-1 (or any other form which includes substantially the same information as would be required to be included in a registration statement on such form as currently constituted), unless the use of a different
form has been agreed to in writing by holders of at least a majority of the Registrable Investor Securities to be included in the proposed registration statement in question (the “Majority Participating Investors”). 
 7.1.3 Payment of Expenses. The Company shall pay all reasonable expenses of holders of Investor Shares incurred in connection with
each registration of Registrable Securities requested pursuant to this Section 7.1, which shall include one legal counsel reasonably acceptable to the Company, other than underwriting discount and commission, if any, and applicable transfer
taxes, if any. 
  

 - 19 - 

 7.1.4 Additional Procedures. In the case of a registration pursuant to
Section 7.1 hereof, whenever the Majority Participating Investors shall request that such registration shall be effected pursuant to an underwritten offering, the Company shall include such information in the written notices to holders of
Registrable Securities referred to in Section 7.2. In such event, the right of any holder of Registrable Securities to have securities owned by such holder included in such registration pursuant to Section 7.1 shall be conditioned upon
such holder’s participation in such underwriting and the inclusion of such holder’s Registrable Securities in the underwriting (unless otherwise mutually agreed upon by the Majority Participating Investors and such holder). If requested by
such underwriters, the Company together with the holders of Registrable Securities proposing to distribute their securities through such underwriting will enter into an underwriting agreement with such underwriters for such offering containing such
representations and warranties by the Company and such holders and such other terms and provisions as are customarily contained in underwriting agreements with respect to secondary distributions, including, without limitation, customary indemnity
and contribution provisions (subject, in each case, to the limitations on such liabilities set forth in this Agreement). 
 7.2. Piggyback Registration Rights. 
 7.2.1 Piggyback Registration. 
 (a) General. Each time the Company proposes to register any shares of Common Stock under the Securities Act on a form which would
permit registration of Registrable Securities for sale to the public, for its own account and/or for the account of an Investor or an Affiliated Fund (pursuant to Section 7.1 or otherwise) for sale in a Public Offering, the Company will give
notice to all holders of Registrable Securities of its intention to do so. Any such holder may, by written response delivered to the Company within 20 days after the effectiveness of such notice, request that all or a specified part of the
Registrable Securities held by such holder be included in such registration. The Company thereupon will use its reasonable efforts to cause to be included in such registration under the Securities Act all shares of Common Stock which the Company has
been so requested to register by such holders, to the extent required to permit the disposition (in accordance with the methods to be used by the Company or other holders of shares of Common Stock in such Public Offering) of the Registrable
Securities to be so registered. No registration of Registrable Securities effected under this Section 7.2 shall relieve the Company of any of its obligations to effect registrations of Registrable Securities pursuant to Section 7.1 hereof.

 (b) Excluded Transactions. The Company shall not be obligated to effect any registration of Registrable Securities
under this Section 7.2 incidental to the registration of any of its securities in connection with: 
 (i) Any Public
Offering relating to employee benefit plans or dividend reinvestment plans; 
  

 - 20 - 

 (ii) Any Public Offering relating to the acquisition or merger after the date hereof by
the Company or any of its subsidiaries of or with any other businesses; or 
 (iii) The Initial Public Offering, unless
(i) such offering shall have been initiated by the Investors pursuant to Section 7.1.1 or (ii) one or more Investors shall have requested that all or a specified part of its Registrable Securities be included in such offering pursuant
to this Section 7.2.1. 
 7.2.2 Payment of Expenses. The Company shall pay all reasonable expenses of a single
legal counsel representing any and all holders of Registrable Securities incurred in connection with each registration of Registrable Securities requested pursuant to this Section 7.2. 
 7.2.3 Additional Procedures. Holders of Shares participating in any Public Offering pursuant to this Section 7.2 shall take
all such actions and execute all such documents and instruments that are reasonably requested by the Company to effect the sale of their Shares in such Public Offering, including, without limitation, being parties to the underwriting agreement
entered into by the Company and any other selling shareholders in connection therewith and being liable in respect of the representations and warranties by, and the other agreements (including without limitation customary selling stockholder
representations, warranties, indemnifications and “lock-up” agreements) for the benefit of the underwriters; provided, however, that (a) with respect to individual representations, warranties, indemnities and agreements
of sellers of Shares in such Public Offering, the aggregate amount of such liability shall not exceed such holder’s net proceeds from such offering and (b) to the extent selling stockholders give further representations, warranties and
indemnities, then with respect to all other representations, warranties and indemnities of sellers of shares in such Public Offering, the aggregate amount of such liability shall not exceed the lesser of (i) such holder’s pro rata portion
of any such liability, in accordance with such holder’s portion of the total number of Shares included in the offering or (ii) such holder’s net proceeds from such offering. 
 7.3. Certain Other Provisions. 
 7.3.1 Underwriter’s Cutback. In connection with any registration of shares, the underwriter may determine that marketing factors (including, without limitation, an adverse effect on the per share offering
price) require a limitation of the number of shares to be underwritten. Notwithstanding any contrary provision of this Section 7 and subject to the terms of this Section 7.3.1, the underwriter may limit the number of shares which would
otherwise be included in such registration by excluding any or all Registrable Securities from such registration (it being understood that the number of shares which the Company seeks to have registered in such registration shall not be subject to
exclusion, in 

  

 - 21 - 

 
whole or in part, under this Section 7.3.1). Upon receipt of notice from the underwriter of the need to reduce the number of shares to be included in
the registration, the Company shall advise all holders of the Company’s securities that would otherwise be registered and underwritten pursuant hereto, and the number of shares of such securities, including Registrable Securities, that may be
included in the registration shall be allocated in the following manner, unless the underwriter shall determine that marketing factors require a different allocation: shares, other than Registrable Securities, requested to be included in such
registration by shareholders shall be excluded unless the Company has, with the consent of the Majority Investors, granted registration rights which are to be treated on an equal basis with Registrable Securities for the purpose of the exercise of
the underwriter cutback; and, if a limitation on the number of shares is still required, the number of Registrable Securities and other shares of Common Stock that may be included in such registration shall be allocated among holders thereof in
proportion, as nearly as practicable, to the respective amounts of Common Stock which each shareholder requested be registered in such registration. For purposes of any underwriter cutback, all Common Stock held by any holder of Registrable
Securities shall also include any Common Stock held by the partners, retired partners, shareholders or affiliated entities of such holder, or the estates and family members of any such holder or such partners and retired partners, any trusts for the
benefit of any of the foregoing persons and, at the election of such holder or such partners, retired partners, trusts or affiliated entities, any Charitable Organization to which any of the foregoing shall have contributed Common Stock prior to the
execution of the underwriting agreement in connection with such underwritten offering, and such holder and other persons shall be deemed to be a single selling holder, and any pro rata reduction with respect to such selling holder shall be based
upon the aggregate amount of Common Stock owned by all entities and individuals included in such selling holder, as defined in this sentence. No securities excluded from the underwriting by reason of the underwriter’s marketing limitation shall
be included in such registration. Upon delivery of a written request that Registrable Securities be included in the underwriting pursuant to Section 7.1.1 or 7.2.1.1, the holder thereof may not thereafter elect to withdraw therefrom without the
written consent the Company and the Majority Investors. 
 7.3.2 Other Actions. If and in each case when the Company is
required to use its best efforts to effect a registration of any Registrable Securities as provided in this Section 7, the Company shall take appropriate and customary actions in furtherance thereof, including, without limitation:
(a) promptly filing with the Commission a registration statement and using reasonable efforts to cause such registration statement to become effective, (b) preparing and filing with the Commission such amendments and supplements to such
registration statements as may be required to comply with the Securities Act and to keep such registration statement effective for a period not to exceed 270 days from the date of effectiveness or such earlier time as the Registrable Securities
covered by such registration statement shall have been disposed of in accordance with the intended method of distribution therefor or the expiration of the time when a prospectus relating to such registration is required to be delivered under the
Securities Act, (c) use its best efforts to register or qualify such Registrable Securities under the state securities or 

  

 - 22 - 

 
“blue sky” laws of such jurisdictions as the sellers shall reasonably request; provided, however, that the Company shall not be
obligated to file any general consent to service of process or to qualify as a foreign corporation in any jurisdiction in which it is not so qualified or to subject itself to taxation in respect of doing business in any jurisdiction in which it
would not otherwise be so subject; and (d) otherwise cooperate reasonably with, and take such customary actions as may reasonably be requested by the holders of Registrable Securities in connection with, such registration. 
 7.3.3 Selection of Underwriters and Counsel. The underwriters and legal counsel to be retained in connection with any Public
Offering shall be selected by the Board or, in the case of an offering following a request therefor under Section 7.1.1, the Initiating Investors, reasonably acceptable to the Company. 
 7.3.4 Lock-Up. Without the prior written consent of the underwriters managing any Public Offering, for a period beginning seven
days immediately preceding and ending on the 90th day (or in the case of the Initial Public Offering, 180th day)
following the effective date of the registration statement used in connection with such offering, neither the Company nor any holder of Shares (whether or not a selling shareholder pursuant to such registration statement) shall (a) offer,
pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase, lend, or otherwise Transfer, directly or indirectly, any shares of Common Stock or any
securities convertible into or exercisable or exchangeable for such Common Stock or (b) enter into any swap or other arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership of Common Stock,
whether any such transaction described in clause (a) or (b) above is to be settled by delivery of such Common Stock or such other securities, in cash or otherwise; provided, however, that the foregoing restrictions shall not
apply to (i) transactions relating to shares of Common Stock or other securities acquired in open market transactions after the completion of the Initial Public Offering, (ii) Transfers to a Permitted Transferee of such holder in
accordance with the terms of this Agreement, (iii) conversions of shares of Common Stock into other classes of Common Stock without change of holder or (iv) during the period preceding the execution of the underwriting agreement in
connection with an underwritten offering, Transfers to a Charitable Organization. 
 7.4. Indemnification and
Contribution. 
 7.4.1 Indemnities of the Company. In the event of any registration of any Registrable Securities
or other debt or equity securities of the Company or any of its subsidiaries under the Securities Act pursuant to this Section 7 or otherwise, and in connection with any registration statement or any other disclosure document produced by or on
behalf of the Company or any of its subsidiaries including, without limitation, reports required and other documents filed under the Exchange Act, and other documents pursuant to which any debt or equity securities of the Company or any of its
subsidiaries are sold (whether or not for the account of the Company or its subsidiaries), each of the Company, Intermediate Holdco and CRC will, and hereby does, and each will cause each 

  

 - 23 - 

 
of its subsidiaries, jointly and severally, to indemnify and hold harmless each seller of Registrable Securities, any Person who is or might be deemed to be
a controlling Person of the Company or any of its subsidiaries within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act, their respective direct and indirect partners, advisory board members, directors,
officers, trustees, members and shareholders, and each other Person, if any, who controls any such seller or any such holder within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act (each such person being
referred to herein as a “Covered Person”), against any losses, claims, damages or liabilities (or actions or proceedings in respect thereof), joint or several, to which such Covered Person may be or become subject under the
Securities Act, the Exchange Act, any other securities or other law of any jurisdiction, the common law or otherwise, insofar as such losses, claims, damages or liabilities (or actions or proceedings in respect thereof) arise out of or are based
upon (i) any untrue statement or alleged untrue statement of any material fact contained or incorporated by reference in any registration statement under the Securities Act, any preliminary prospectus or final prospectus included therein, or
any related summary prospectus, or any amendment or supplement thereto, or any document incorporated by reference therein, or any other such disclosure document (including without limitation reports and other documents filed under the Exchange Act
and any document incorporated by reference therein) or other document or report, (ii) any omission or alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading or
(iii) any violation or alleged violation by the Company or any of its subsidiaries of any federal, state, foreign or common law rule or regulation applicable to the Company or any of its subsidiaries and relating to action or inaction in
connection with any such registration, disclosure document or other document or report, and will reimburse such Covered Person for any legal or any other expenses incurred by it in connection with investigating or defending any such loss, claim,
damage, liability, action or proceeding; provided, however, that none of the Company, Intermediate Holdco or CRC, nor any of their respective subsidiaries, shall be liable to any Covered Person in any such case to the extent that any
such loss, claim, damage, liability, action or proceeding arises out of or is based upon an untrue statement or alleged untrue statement or omission or alleged omission made in such registration statement, any such preliminary prospectus, final
prospectus, summary prospectus, amendment or supplement, incorporated document or other such disclosure document or other document or report, in reliance upon and in conformity with written information furnished to the Company, Intermediate Holdco,
CRC or to any of their respective subsidiaries through an instrument duly executed by such Covered Person specifically stating that it is for use in the preparation thereof. The indemnities of the Company and of its subsidiaries contained in this
Section 7.4.1 shall remain in full force and effect regardless of any investigation made by or on behalf of such Covered Person and shall survive any transfer of securities. 
 7.4.2 Indemnities to the Company. The Company and any of its subsidiaries may require, as a condition to including any securities
in any registration statement filed pursuant to this Section 7, that the Company and any of its subsidiaries shall have 

  

 - 24 - 

 
received an undertaking satisfactory to it from the prospective seller of such securities, to indemnify and hold harmless the Company and any of its
subsidiaries, each director of the Company or any of its subsidiaries, each officer of the Company or any of its subsidiaries who shall sign such registration statement and each other Person (other than such seller), if any, who controls the Company
and any of its subsidiaries within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act and each other prospective seller of such securities with respect to any statement in or omission from such registration
statement, any preliminary prospectus, final prospectus or summary prospectus included therein, or any amendment or supplement thereto, or any other disclosure document (including, without limitation, reports and other documents filed under the
Exchange Act or any document incorporated therein) or other document or report, if such statement or omission was made in reliance upon and in conformity with written information furnished to the Company or any of its subsidiaries through an
instrument executed by such seller specifically stating that it is for use in the preparation of such registration statement, preliminary prospectus, final prospectus, summary prospectus, amendment or supplement, incorporated document or other
document or report. Such indemnity shall remain in full force and effect regardless of any investigation made by or on behalf of the Company, any of its subsidiaries or any such director, officer or controlling Person and shall survive any transfer
of securities. 
 7.4.3 Contribution. If the indemnification provided for in Sections 7.4.1 or 7.4.2 hereof
is unavailable to a party that would have been entitled to indemnification pursuant to the foregoing provisions of this Section 7.4 (an “Indemnitee”) in respect of any losses, claims, damages or liabilities (or actions or
proceedings in respect thereof) referred to therein, then each party that would have been an indemnifying party thereunder shall, in lieu of indemnifying such Indemnitee, contribute to the amount paid or payable by such Indemnitee as a result of
such losses, claims, damages or liabilities (or actions or proceedings in respect thereof) in such proportion as is appropriate to reflect the relative fault of such indemnifying party on the one hand and such Indemnitee on the other in connection
with the statements or omissions which resulted in such losses, claims, damages or liabilities (or actions or proceedings in respect thereof). The relative fault shall be determined by reference to, among other things, whether the untrue or alleged
untrue statement of a material fact or the omission or alleged omission to state a material fact relates to information supplied by such indemnifying party or such Indemnitee and the parties’ relative intent, knowledge, access to information
and opportunity to correct or prevent such statement or omission. The parties agree that it would not be just or equitable if contribution pursuant to this Section 7.4.3 were determined by pro rata allocation or by any other method of
allocation which does not take account of the equitable considerations referred to in the preceding sentence. The amount paid or payable by a contributing party as a result of the losses, claims, damages or liabilities (or actions or proceedings in
respect thereof) referred to above in this Section 7.4.3 shall include any legal or other expenses reasonably incurred by such Indemnitee in connection with investigating or defending any such action or claim. No Person guilty of fraudulent
misrepresentation (within the meaning of Section 11(f) of the Securities Act) shall be entitled to contribution from any Person who was not guilty of such fraudulent misrepresentation. 
  

 - 25 - 

 7.4.4 Limitation on Liability of Holders of Registrable Securities. The liability
of each holder of Registrable Securities in respect of any indemnification or contribution obligation of such holder arising under this Section 7.4 shall not in any event exceed an amount equal to the net proceeds to such holder (after
deduction of all underwriters’ discounts and commissions) from the disposition of the Registrable Securities disposed of by such holder pursuant to such registration. 
 8. REMEDIES. 
 8.1.
Generally. The Company and each holder of Shares shall have all remedies available at law, in equity or otherwise in the event of any breach or violation of this Agreement or any default hereunder by the Company or any holder of Shares. The
parties acknowledge and agree that in the event of any breach of this Agreement, in addition to any other remedies which may be available, each of the parties hereto shall be entitled to specific performance of the obligations of the other parties
hereto and, in addition, to such other equitable remedies (including, without limitation, preliminary or temporary relief) as may be appropriate in the circumstances. 
 8.2. Deposit. Without limiting the generality of Section 8.1, if any holder of Shares fails to deliver to the purchaser
thereof the certificate or certificates evidencing Shares to be Sold pursuant to Section 4 or 5 hereof, such purchaser may, at its option, in addition to all other remedies it may have, deposit the purchase price (including any promissory note
constituting all or any portion thereof) for such Shares with any national bank or trust company having combined capital, surplus and undivided profits in excess of One Hundred Million Dollars ($100,000,000) (the “Escrow Agent”) and
the Company shall cancel on its books the certificate or certificates representing such Shares and thereupon all of such holder’s rights in and to such Shares shall terminate. Thereafter, upon delivery to such purchaser by such holder of the
certificate or certificates evidencing such Shares (duly endorsed, or with stock powers duly endorsed, for transfer, with signature guaranteed, free and clear of any liens or encumbrances, and with any transfer tax stamps affixed), such purchaser
shall instruct the Escrow Agent to deliver the purchase price (without any interest from the date of the closing to the date of such delivery, any such interest to accrue to such purchaser) to such holder. 
 9. LEGENDS. 
 9.1.
Restrictive Legend. Each certificate representing Shares shall have the following legend endorsed conspicuously thereupon: 
 The voting of the shares of stock represented by this certificate, and the sale, encumbrance or other disposition thereof, are subject to the provisions of a Stockholders Agreement to which the issuer and certain of its stockholders are
party, a copy of which may be inspected at the principal office of the issuer or obtained from the issuer without charge. 
  

 - 26 - 

 Each certificate representing Investor Shares shall also have the following legend endorsed conspicuously
thereupon: 
 The shares of stock represented by this certificate were originally issued to, or issued with respect to shares
originally issued to, the following Investor:                         . 
 Each certificate representing Other Investor Shares shall also have the following legend endorsed conspicuously thereupon: 
 The shares of stock represented by this certificate were originally issued to, or issued with respect to shares originally issued to, the
following Other Investor:                         . 
 Each certificate representing Management Shares shall also have the following legend endorsed conspicuously thereupon: 
 The shares of stock represented by this certificate were originally issued to, or issued with respect to shares originally issued to, the
following Manager:                         . 
 Any person who acquires Shares which are not subject to all or part of the terms of this Agreement shall have the right to have such legend (or the
applicable portion thereof) removed from certificates representing such Shares. 
 9.2. 1933 Act Legends. Each
certificate representing Shares shall have the following legend endorsed conspicuously thereupon: 
 The securities
represented by this certificate were issued in a private placement, without registration under the Securities Act of 1933, as amended (the “Act”), and may not be sold, assigned, pledged or otherwise transferred in the absence of an
effective registration under the Act covering the transfer or an opinion of counsel, satisfactory to the issuer, that registration under the Act is not required. 
 9.3. Stop Transfer Instruction. The Company will instruct any transfer agent not to register the Transfer of any Shares until the
conditions specified in the foregoing legends are satisfied. 
 9.4. Termination of 1933 Act Legend. The requirement
imposed by Section 9.2 hereof shall cease and terminate as to any particular Shares (a) when, in the opinion of Ropes & Gray LLP, or other counsel reasonably acceptable to the Company, such legend is no longer required in order to
assure compliance by the Company with the Securities Act or (b) when such Shares have been effectively registered under the Securities Act or transferred pursuant to Rule 144. Wherever (x) such requirement shall cease and terminate as to
any Shares or (y) such Shares shall be transferable under paragraph (k) of Rule 144, the holder thereof shall be entitled to receive from the Company, without expense, new certificates not bearing the legend set forth in Section 9.2
hereof. 
  

 - 27 - 

 10. AMENDMENT, TERMINATION, ETC. 
 10.1. Oral Modifications. This Agreement may not be orally amended, modified, extended or terminated, nor shall any oral waiver of
any of its terms be effective. 
 10.2. Written Modifications. This Agreement may be amended, modified, extended or
terminated, and the provisions hereof may be waived, only by an agreement in writing signed by the Majority Investors; provided, however, that (a) the consent of the Majority Other Investors shall be required for any amendment,
modification, extension, termination or waiver which has a disproportionate and material adverse effect on the rights of the holders of Other Investor Shares as such under this Agreement and (b) the consent of the Majority Managers shall be
required for any amendment, modification, extension, termination or waiver which has a disproportionate and material adverse effect on the rights of the holders of Management Shares as such under this Agreement. Each such amendment, modification,
extension, termination and waiver shall be binding upon each party hereto and each holder of Shares subject hereto. In addition, each party hereto and each holder of Shares subject hereto may waive any right hereunder by an instrument in writing
signed by such party or holder. 
 10.3. Effect of Termination. No termination under this Agreement shall relieve any
Person of liability for breach prior to termination. 
 11. DEFINITIONS. For purposes of this Agreement: 
 11.1. Certain Matters of Construction. In addition to the definitions referred to or set forth below in this Section 11:

 (a) The words “hereof”, “herein”, “hereunder” and words of similar import shall refer to this
Agreement as a whole and not to any particular Section or provision of this Agreement, and reference to a particular Section of this Agreement shall include all subsections thereof; 
 (b) Definitions shall be equally applicable to both nouns and verbs and the singular and plural forms of the terms defined; and

 (c) The masculine, feminine and neuter genders shall each include the other. 
 11.2. Definitions. The following terms shall have the following meanings: 
 “Adverse Claim” shall have the meaning set forth in Section 8-302 of the applicable Uniform Commercial Code. 
 “Affiliate” shall mean, with respect to any specified Person, (a) any other Person which directly or indirectly through one or more
intermediaries controls, or is controlled by, or is under common control with, such specified Person (for the purposes of this definition, “control” (including, with correlative meanings, the terms “controlling,” “controlled
by” and “under common control with”), as used with respect to any Person, means the possession, directly or indirectly, of the power to direct or cause the direction of the management or policies of such 

  

 - 28 - 

 
Person, whether through the ownership of voting securities, by agreement or otherwise) and (b) with respect to any natural Person, any Member of the
Immediate Family of such natural Person. 
 “Affiliated Fund” shall mean each corporation, trust, limited liability company,
general or limited partnership or other entity under common control with any Investor or that receives investment advice from the investment adviser to any Investor or an investment adviser affiliated with such investment adviser. 
 “Agreement” shall have the meaning set forth in the Preamble. 
 “Board” shall have the meaning set forth in Section 2.1. 
 “Call Notice” shall have the meaning set forth in Section 5.1.3. 
 “Cause” with respect to any holder of Management Shares, a termination by the Company of such Manager’s employment with the Company
or an Affiliate of the Company or a termination by such Manager of the Manager’s employment with the Company or an Affiliate of the Company, in either case following the occurrence of any of the following events: (i) the willful failure by
the Manager to substantially perform his duties with the Company or any Affiliate (other than any such failure due to the Manager’s physical or mental illness); (ii) the Manager’s gross negligence, gross or willful misconduct or
illegal conduct in the performance of his or her duties for the Company or any Affiliate which has resulted in or is reasonably expected to result in injury to the Company or any Affiliate; (iii) the Manager’s conviction of, or entering a
plea of guilty or nolo contendere to, a misdemeanor involving theft or embezzlement, or a felony; or (iv) the breach by the Manager of any obligations under any written agreement or covenant with the Company or any of its Affiliates
which breach has resulted in or is reasonably expected to result in injury to the Company or any Affiliates. Notwithstanding the foregoing, if the Manager is party to an employment or severance agreement with the Company that contains a definition
of cause, such definition shall apply (in the case of such Manager) in lieu of the definition set forth in the preceding sentence. 
 “Change of Control” shall mean (a) any change in the ownership of the capital stock of the Company if, immediately after giving effect thereto, any Person (or group of Persons acting in concert) other than the
Investors and their Affiliates will have the direct or indirect power to elect a majority of the members of the Board or (b) any change in the ownership of the capital stock of the Company if, immediately after giving effect thereto, the
Investors and their Affiliates shall own less than 25% of the Equivalent Shares. 
 “Charitable Organization” shall mean a
charitable organization as described by Section 501(c)(3) of the Internal Revenue Code of 1986, as in effect from time to time. 
 “Class A Stock” shall mean the Class A Common Stock, par value $.001 per share of the Company. 
  

 - 29 - 

 “Class L Stock” shall mean the Class L Common Stock, par value $.001 per share, of the
Company. 
 “Closing” shall have the meaning set forth in Section 1.1. 
 “Commission” shall mean the Securities and Exchange Commission. 
 “Common Stock” shall mean the common stock of the Company including without limitation the Class A Stock and the Class L
Stock. 
 “Company” shall have the meaning set forth in the Preamble. 
 “Convertible Securities” shall mean any evidence of indebtedness, shares of stock (other than Common Stock) or other securities (other
than Options and Warrants) which are directly or indirectly convertible into or exchangeable or exercisable for shares of Common Stock. 
 “Cost” shall mean, for any security, the price paid to the issuer for such security. 
 “Covered
Person” shall have the meaning set forth in Section 7.4.1. 
 “CRC” shall have the meaning set forth in the
Preamble. 
 “Determination Time” shall have the meaning set forth in Section 3.3. 
 “Drag Along Notice” shall have the meaning set forth in Section 4.2.1. 
 “Drag Along Sale Percentage” shall have the meaning set forth in Section 4.2. 
 “Drag Along Sellers” shall have the meaning set forth in Section 4.2.1. 
 “Equivalent Shares” shall mean, at any date of determination, (a) as to any outstanding shares of Common Stock, such number of
shares of Common Stock, (b) as to any outstanding Options, Warrants or Convertible Securities which constitute Investor Shares or Other Investor Shares, the maximum number of shares of Common Stock for which or into which such Options, Warrants
or Convertible Securities may at the time be exercised, converted or exchanged (or which will become exercisable, convertible or exchangeable on or prior to, or by reason of, the transaction or circumstance in connection with which the number of
Equivalent Shares is to be determined) and (c) as to any outstanding Rollover Options, the maximum number of shares of Common Stock for which or into which such Rollover Options may at the time be exercised, converted or exchanged (or which
will become exercisable, convertible or exchangeable on or prior to, or by reason of, the transaction or circumstance in connection with which the number of Equivalent Shares is to be determined). 
 “Escrow Agent” shall have the meaning set forth in Section 8.2. 
 “Exchange Act” shall mean the Securities Exchange Act of 1934, as in effect from time to time. 
  

 - 30 - 

 “Fair Market Value” shall mean, as of any date, as to any share of Common Stock, the
Board’s good faith determination of the fair value of such share as of the applicable reference date. 
 “Indemnitee”
shall have the meaning set forth in Section 7.4.3. 
 “Initial Public Offering” means the initial Public Offering
registered on Form S-1 (or any successor form under the Securities Act). 
 “Initiating Investors” shall have the
meaning set forth in Section 7.1.1. 
 “Intermediate Holdco” shall have the meaning set forth in the Preamble.

 “Investor Shares” shall mean (a) all shares of Common Stock originally issued to, or issued with respect to shares
originally issued to, or held by, an Investor, whenever issued, including, without limitation, all shares of Common Stock issued upon the exercise, conversion or exchange of any Options, Warrants or Convertible Securities and (b) all Options,
Warrants and (except for purposes of Section 4.1) Convertible Securities originally granted or issued to an Investor (treating such Options, Warrants and Convertible Securities as a number of Shares equal to the number of Equivalent Shares
represented by such Options, Warrants and Convertible Securities for all purposes of this Agreement except as otherwise specifically set forth herein). 
 “Investors” shall have the meaning set forth in the Preamble. 
 “Issuance”
shall have the meaning set forth in Section 6. 
 “Majority Investors” shall mean, as of any date, the holders of a
majority of the Investor Shares outstanding on such date. 
 “Majority Managers” shall mean, as of any date, the holders of
a majority of the Management Shares outstanding on such date. 
 “Majority Other Investors” shall mean, as of any date, the
holders of a majority of the Other Investor Shares outstanding on such date. 
 “Majority Participating Investors” shall
have the meaning set forth in Section 7.2.1. 
 “Management Call Group” shall have the meaning set forth in
Section 5.1. 
 “Management Call Notice” shall have the meaning set forth in Section 5.1.4. 
 “Management Call Option” shall have the meaning set forth in Section 5.1. 
 “Management Incentive Shares” shall mean those Management Shares held by a Manager pursuant to a grant under the Company’s 2006
Management Incentive Plan. 
  

 - 31 - 

 “Management Shares” shall mean (a) all shares of Common Stock originally issued to,
or issued with respect to shares originally issued to, or held by, a Manager, whenever issued, including without limitation all shares of Common Stock issued upon the exercise, conversion or exchange of any Options, Warrants or Convertible
Securities and (b) all Options, Warrants and (except for purposes of Section 4.1) Convertible Securities originally granted or issued to a Manager (treating such Options, Warrants and Convertible Securities as a number of Shares equal to
the number of Equivalent Shares represented by such Options, Warrants and Convertible Securities for all purposes of this Agreement except (i) for purposes of Section 6 and (ii) as otherwise specifically set forth herein). 

“Managers” shall have the meaning set forth in the Preamble. 
 “Members of the Immediate Family” shall mean, with respect to any individual, each spouse or child or other descendants of such
individual, each trust created solely for the benefit of one or more of the aforementioned Persons and their spouses and each custodian or guardian of any property of one or more of the aforementioned Persons in his capacity as such custodian or
guardian. 
 “Merger” shall mean the merger of MergerCo with and into CRC as provided in the Merger Agreement. 

“Merger Agreement” shall have the meaning set forth in the Recitals. 
 “MergerCo” shall have the meaning set forth in the Recitals. 
 “Option Shares” shall mean, with respect to a Manager or direct or indirect Permitted Transferee of a Manager, all or any portion of the
Management Shares which were issued upon exercise of an Option held by such holder (or Permitted Transferee, if applicable). 
 “Options” shall mean any options to subscribe for, purchase or otherwise directly acquire Common Stock. 
 “Other Investor Shares” shall mean (a) all shares of Common Stock originally issued to, or issued with respect to shares originally issued to, or held by, an Other Investor, whenever issued, including without
limitation all shares of Common Stock issued upon the exercise, conversion or exchange of any Options, Warrants or Convertible Securities and (b) all Options, Warrants and (except for purposes of Section 4.1) Convertible Securities
originally granted or issued to an Other Investor (treating such Options, Warrants and Convertible Securities as a number of Shares equal to the number of Equivalent Shares represented by such Options, Warrants and Convertible Securities for all
purposes of this Agreement except as otherwise specifically set forth herein). 
 “Other Investors” shall have the meaning
set forth in the Preamble. 
 “Other Securities” shall have the meaning set forth in Section 6.1.3. 
 “Participating Buyer” shall have the meaning set forth in Section 6.1.2. 
  

 - 32 - 

 “Participating Seller” shall have the meaning set forth in Section 4.1.2
and 4.2.1. 
 “Participation Notice” shall have the meaning set forth in Section 6.1.1. 
 “Participation Offerees” shall have the meaning set forth in Section 6.1.1. 
 “Participation Portion” shall have the meaning set forth in Section 6.1.1. 
 “Permitted Transferee” shall have the meaning set forth in Section 3.1. 
 “Person” shall mean any individual, partnership, corporation, company, association, trust, joint venture, limited liability company,
unincorporated organization, entity or division, or any government, governmental department or agency or political subdivision thereof. 
 “Price Per Equivalent Share” shall mean the Board’s good faith determination of the price per Equivalent Share of any Convertible Securities or Options which are the subject of an Issuance pursuant to Section 6
hereof. 
 “Prospective Buyer” shall mean any Person proposing to purchase shares from a Prospective Selling Investor.

 “Prospective Selling Investor” shall have the meaning set forth in Section 4.1 and 4.2. 
 “Prospective Subscriber” shall have the meaning set forth in Section 6.1.1. 
 “Public Offering” shall mean a public offering and sale of Common Stock for cash pursuant to an effective registration statement under
the Securities Act. 
 “Purchased Management Shares” shall mean, with respect to a Manager or direct or indirect Permitted
Transferee of a Manager, all of the Management Shares which are not Options held by such holder (or Permitted Transferee, if applicable). 
 “Qualified Public Offering” shall mean a Public Offering, other than any Public Offering or sale pursuant to a registration statement on Form S-8 or comparable form, in which the aggregate price to the public of all such
common stock sold in such offering shall exceed $50,000,000. 
 “Registrable Investor Securities” shall have the meaning set
forth in Section 7.1.1. 
 “Registrable Securities” shall mean (a) all shares of Class A Stock, (b) all
shares of Class A Stock issuable upon conversion of Shares of Class L Stock, (c) all shares of Class A Stock issuable upon exercise, conversion or exchange of any Option, Warrant or Convertible Security and (d) all shares of
Class A Stock directly or indirectly issued or issuable with respect to the securities referred to in clauses (a), (b) or (c) above by way of stock dividend or stock split or in connection with a combination of shares,
recapitalization, merger, consolidation or other reorganization, in each case constituting Shares. As to any particular Registrable Securities, such shares shall cease to be Registrable Securities when (v) such shares shall have been
Transferred 

  

 - 33 - 

 
in a Sale to which Section 4.1 or 4.2 apply, (w) a registration statement with respect to the sale of such securities shall have become effective
under the Securities Act and such securities shall have been disposed of in accordance with such registration statement, (x) such securities shall have been Transferred pursuant to Rule 144, (y) subject to the provisions of Section 10
hereof, such securities shall have been otherwise transferred, new certificates for them not bearing a legend restricting further transfer shall have been delivered by the Company and subsequent disposition of them shall not require registration of
them under the Securities Act, (z) such securities may be distributed without volume limitation or other restrictions on transfer under Rule 144 (including without application of paragraphs (c), (e) (f) and (h) of Rule 144) or
(zz) such securities shall have ceased to be outstanding. 
 “Regulation D” shall mean Regulation D under the
Securities Act. 
 “Relative Ownership Percentage” shall have the meaning set forth in Section 3.3. 
 “Rollover Options” shall mean those Options granted to Managers in substitution for options of CRC granted to such Manager prior to the
Merger. 
 “Rollover Option Shares” shall mean, at any time, any Option Shares that result from any Rollover Options.

 “Rule 144” shall mean Rule 144 under the Securities Act (or any successor Rule). 
 “Rule 145 Transaction” shall mean a registration on Form S-4 pursuant to Rule 145 of the Securities Act (or any successor Form
or provision, as applicable). 
 “Sale” shall mean a Transfer for value. 
 “Sale Transaction” shall mean (i) any change in the ownership of the capital stock of the Company if, immediately after giving
effect thereto, any Person (or group of Persons acting in concert) other than the Investors and their Affiliates will have the direct or indirect power to elect a majority of the members of the Board, or (ii) a sale or transfer of all or
substantially all of the Company’s assets to a Person who is not an Affiliate of the Company. 
 “Securities Act” shall
mean the Securities Act of 1933, as in effect from time to time. 
 “Shares” shall mean all Investor Shares, Other Investor
Shares and Management Shares. 
 “Stockholder Call Group” shall have the meaning set forth in Section 5.1. 

“Stockholders” shall have the meaning set forth in the Preamble. 
 “Subject Securities” shall have the meaning set forth in Section 6. 
 “Tag Along Notice” shall have the meaning set forth in Section 4.1.1. 
 “Tag Along Offerees” shall have the meaning set forth in Section 4.1.1. 
  

 - 34 - 

 “Tag Along Sale Percentage” shall have the meaning set forth in Section 4.1.1.

 “Tag Along Sellers” shall have the meaning set forth in Section 4.1.2. 
 “Transfer” shall mean any sale, pledge, assignment, encumbrance or other transfer or disposition of any Shares to any other Person,
whether directly, indirectly, voluntarily, involuntarily, by operation of law, pursuant to judicial process or otherwise. 
 “Warrants” shall mean any warrants to subscribe for, purchase or otherwise directly acquire Common Stock. 
 12.
MISCELLANEOUS. 
 12.1. Authority; Effect. Each party hereto represents and warrants to and agrees with each other
party that the execution and delivery of this Agreement and the consummation of the transactions contemplated hereby have been duly authorized on behalf of such party and do not violate any agreement or other instrument applicable to such party or
by which its assets are bound. This Agreement does not, and shall not be construed to, give rise to the creation of a partnership among any of the parties hereto, or to constitute any of such parties members of a joint venture or other association.
Except where the context otherwise requires, Acquisition shall be jointly and severally liable for all obligations of the Company pursuant to this Agreement. 
 12.2. Notices. All notices, requests, demands, claims and other communications required or permitted to be delivered, given or
otherwise provided under this Agreement must be in writing and must be delivered, given or otherwise provided: 
 (a) by hand
(in which case, it will be effective upon delivery); 
 (b) by facsimile (in which case, it will be effective upon receipt of
confirmation of good transmission); or 
 (c) by overnight delivery by a nationally recognized courier service (in which
case, it will be effective on the Business Day after being deposited with such courier service); 
 in each case, to the
address (or facsimile number) listed below 
 If to the Company, to them: 
 CRC Health Group, Inc. 
 20400 Stevens Creek Blvd, 6th Floor 
 Cupertino, CA 95014 
 Attention: General Counsel 
 with a copy to: 
  

 - 35 - 

 DLA Piper Rudnick Gray Cary US, LLP 
 2000 University Avenue 
 East Palo Alto, CA 94303 
 Attention: Bruce Schaeffer 
 If to the Company or an Investor, to them: 
 c/o Bain Capital Partners, LLC 
 111 Huntington Ave. 
 Boston, MA 02199 
 Attention: John Connaughton, Steve Barnes, and Chris Gordon 
 with a copy to: 
 Ropes & Gray 
 One International Place 
 Boston, Massachusetts 02110 
 Attention: Alfred O. Rose, Esq. 
 If to an Other Investor or a Manager, to him at the address set forth in the stock record book of the Company. 
 Notice to the
holder of record of any shares of capital stock shall be deemed to be notice to the holder of such shares for all purposes hereof. 
 Unless
otherwise specified herein, such notices or other communications shall be deemed effective (a) on the date received, if personally delivered, (b) two business days after being sent by Federal Express, DHL or UPS and (c) three business
days after deposit with the U.S. Postal Service, if sent by registered or certified mail. Each of the parties hereto shall be entitled to specify a different address by giving notice as aforesaid to each of the other parties hereto. 
 12.3. Binding Effect, Etc. Except for restrictions on Transfer of Shares set forth in other agreements, plans or other documents,
this Agreement constitutes the entire agreement of the parties with respect to its subject matter, supersedes all prior or contemporaneous oral or written agreements or discussions with respect to such subject matter, and shall be binding upon and
inure to the benefit of the parties hereto and their respective heirs, representatives, successors and assigns. 
 12.4.
Descriptive Headings. The descriptive headings of this Agreement are for convenience of reference only, are not to be considered a part hereof and shall not be construed to define or limit any of the terms or provisions hereof. 
  

 - 36 - 

 12.5. Counterparts. This Agreement may be executed in multiple counterparts, each
of which shall be deemed an original, but all of which taken together shall constitute one instrument. 
 12.6.
Severability. In the event that any provision hereof would, under applicable law, be invalid or unenforceable in any respect, such provision shall be construed by modifying or limiting it so as to be valid and enforceable to the maximum
extent compatible with, and possible under, applicable law. The provisions hereof are severable, and in the event any provision hereof should be held invalid or unenforceable in any respect, it shall not invalidate, render unenforceable or otherwise
affect any other provision hereof. 
 13. GOVERNING LAW. 
 13.1. Governing Law. This Agreement shall be governed by and construed in accordance with the domestic substantive laws of the
State of Delaware without giving effect to any choice or conflict of laws provision or rule that would cause the application of the domestic substantive laws of any other jurisdiction. 
 13.2. Consent to Jurisdiction. Each party to this Agreement, by its execution hereof, (a) hereby irrevocably submits to the
exclusive jurisdiction of the state and federal courts sitting in the State of New York for the purpose of any action, claim, cause of action or suit (in contract, tort or otherwise), inquiry, proceeding or investigation arising out of or based upon
this Agreement or relating to the subject matter hereof, (b) hereby waives to the extent not prohibited by applicable law, and agrees not to assert, and agrees not to allow any of its subsidiaries to assert, by way of motion, as a defense or
otherwise, in any such action, any claim that it is not subject personally to the jurisdiction of the above-named courts, that its property is exempt or immune from attachment or execution, that any such proceeding brought in one of the above-named
courts is improper, or that this Agreement or the subject matter hereof or thereof may not be enforced in or by such court and (c) hereby agrees not to commence or maintain any action, claim, cause of action or suit (in contract, tort or
otherwise), inquiry, proceeding or investigation arising out of or based upon this Agreement or relating to the subject matter hereof or thereof other than before one of the above-named courts nor to make any motion or take any other action seeking
or intending to cause the transfer or removal of any such action, claim, cause of action or suit (in contract, tort or otherwise), inquiry, proceeding or investigation to any court other than one of the above-named courts whether on the grounds of
inconvenient forum or otherwise. Notwithstanding the foregoing, to the extent that any party hereto is or becomes a party in any litigation in connection with which it may assert indemnification rights set forth in this agreement, the court in which
such litigation is being heard shall be deemed to be included in clause (a) above. Each party hereto hereby consents to service of process in any such proceeding in any manner permitted by Delaware law, and agrees that service of process by
registered or certified mail, return receipt requested, at its address specified pursuant to Section 13.2 hereof is reasonably calculated to give actual notice. 
 13.3. WAIVER OF JURY TRIAL. TO THE EXTENT NOT PROHIBITED BY APPLICABLE LAW WHICH CANNOT BE WAIVED, EACH PARTY HERETO 

  

 - 37 - 

 
HEREBY WAIVES AND COVENANTS THAT IT WILL NOT ASSERT (WHETHER AS PLAINTIFF, DEFENDANT OR OTHERWISE) ANY RIGHT TO TRIAL BY JURY IN ANY FORUM IN RESPECT OF ANY
ISSUE OR ACTION, CLAIM, CAUSE OF ACTION OR SUIT (IN CONTRACT, TORT OR OTHERWISE), INQUIRY, PROCEEDING OR INVESTIGATION ARISING OUT OF OR BASED UPON THIS AGREEMENT OR THE SUBJECT MATTER HEREOF OR IN ANY WAY CONNECTED WITH OR RELATED OR INCIDENTAL TO
THE TRANSACTIONS CONTEMPLATED HEREBY, IN EACH CASE WHETHER NOW EXISTING OR HEREAFTER ARISING. EACH PARTY HERETO ACKNOWLEDGES THAT IT HAS BEEN INFORMED BY THE OTHER PARTIES HERETO THAT THIS SECTION 13.3 CONSTITUTES A MATERIAL INDUCEMENT UPON WHICH
THEY ARE RELYING AND WILL RELY IN ENTERING INTO THIS AGREEMENT. ANY PARTY HERETO MAY FILE AN ORIGINAL COUNTERPART OR A COPY OF THIS SECTION 13.3 WITH ANY COURT AS WRITTEN EVIDENCE OF THE CONSENT OF EACH SUCH PARTY TO THE WAIVER OF ITS RIGHT TO TRIAL
BY JURY. 
 13.4. Exercise of Rights and Remedies. No delay of or omission in the exercise of any right, power or
remedy accruing to any party as a result of any breach or default by any other party under this Agreement shall impair any such right, power or remedy, nor shall it be construed as a waiver of or acquiescence in any such breach or default, or of any
similar breach or default occurring later; nor shall any such delay, omission nor waiver of any single breach or default be deemed a waiver of any other breach or default occurring before or after that waiver. 
  

 - 38 - 

 IN WITNESS WHEREOF, each of the undersigned has duly executed this Agreement (or caused this Agreement to
be executed on its behalf by its officer or representative thereunto duly authorized) under seal as of the date first above written. 
  

					
	THE COMPANY:	 	CRC HEALTH GROUP, INC.
			
		 	By:	 	 /s/ Kevin Hogge

		 	Name:	 	Kevin Hogge
		 	Title:	 	Chief Financial Officer
		
	INTERMEDIATE HOLDCO:	 	CRC INTERMEDIATE HOLDINGS, INC.
			
		 	By:	 	 /s/ Kevin Hogge

		 	Name:	 	Kevin Hogge
		 	Title:	 	Chief Financial Officer
		
	CRC:	 	CRC HEALTH CORPORATION
			
		 	By:	 	 /s/ Kevin Hogge

		 	Name:	 	Kevin Hogge
		 	Title:	 	Chief Financial Officer

 [SIGNATURES CONTINUED ON NEXT PAGE] 
 Shareholder Agreement 

					
	THE INVESTORS:	 	BAIN CAPITAL FUND VIII, LLC
		 	By: Bain Capital Fund VIII, L.P., its sole member
		
		 	By: Bain Capital Partners VIII, L.P., its general partner
		
		 	By: Bain Capital Investors, LLC, its general partner
			
		 	By:	 	 /s/ John Connaughton

		 	Name:	 	John Connaughton
		 	Title:	 	Managing Director
		
		 	BAIN CAPITAL COINVESTMENT FUND VIII, LLC
		 	By: Bain Capital VIII Coinvestment Fund, L.P., its sole member
		
		 	By: Bain Capital Partners VIII, L.P., its general partner
		
		 	By: Bain Capital Investors, LLC, its general partner
			
		 	By:	 	 /s/ John Connaughton

		 	Name:	 	John Connaughton
		 	Title:	 	Managing Director
		
		 	BCIP ASSOCIATES-G
		 	By: Bain Capital Investors, LLC, its managing partner
			
		 	By:	 	 /s/ John Connaughton

		 	Name:	 	John Connaughton
		 	Title:	 	Managing Director

 [SIGNATURES CONTINUED ON NEXT PAGE] 
 Shareholder Agreement 

					
		 	BCIP ASSOCIATES III, LLC
		 	By: BCIP Associates III, its manager
		
		 	By: Bain Capital Investors, LLC, its managing partner
			
		 	By:	 	 /s/ John Connaughton

		 	Name:	 	John Connaughton
		 	Title:	 	Managing Director
		
		 	BCIP T ASSOCIATES III, LLC
		 	By: Bain Trust Associates III, its manager
		
		 	By: Bain Capital Investors, LLC, its managing partner
			
		 	By:	 	 /s/ John Connaughton

		 	Name:	 	John Connaughton
		 	Title:	 	Managing Director
		
		 	BCIP ASSOCIATES III-B, LLC
		 	By: BCIP Associates III-B, its manager
		
		 	By: Bain Capital Investors, LLC, its managing partner
			
		 	By:	 	 /s/ John Connaughton

		 	Name:	 	John Connaughton
		 	Title:	 	Managing Director
		
		 	BCIP T ASSOCIATES III-B, LLC
		 	By: BCIP Trust Associates III-B, its manager
		
		 	By: Bain Capital Investors, LLC, its managing partner
			
		 	By:	 	 /s/ John Connaughton

		 	Name:	 	John Connaughton
		 	Title:	 	Managing Director

 [SIGNATURES CONTINUED ON NEXT PAGE] 
 Shareholder Agreement 

					
	THE OTHER INVESTORS:	 	RGIP, LLC
			
		 	By:	 	 /s/ R. Bradford Malt

		 	Name:	 	R. Bradford Malt
		 	Title:	 	Managing Member

 [SIGNATURES CONTINUED ON NEXT PAGE] 
 Shareholder Agreement 

			
	MANAGEMENT:	 	
		 	 /s/ Dr. Barry Karlin

		 	Dr. Barry Karlin

 Shareholder Agreement

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00105-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00105-of-00352.parquet"}]]